BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yu T, Guo F, Yu Y, Sun T, Ma D, Han J, Qian Y, Kryczek I, Sun D, Nagarsheth N, Chen Y, Chen H, Hong J, Zou W, Fang JY. Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy. Cell. 2017;170:548-563.e16. [PMID: 28753429 DOI: 10.1016/j.cell.2017.07.008] [Cited by in Crossref: 531] [Cited by in F6Publishing: 543] [Article Influence: 106.2] [Reference Citation Analysis]
Number Citing Articles
1 Scott TA, Quintaneiro LM, Cabreiro F. Microbiome genetics underpins chemotherapy. Oncotarget 2017;8:93303-4. [PMID: 29212144 DOI: 10.18632/oncotarget.22066] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
2 Kaźmierczak-Siedlecka K, Roviello G, Catalano M, Polom K. Gut Microbiota Modulation in the Context of Immune-Related Aspects of Lactobacillus spp. and Bifidobacterium spp. in Gastrointestinal Cancers. Nutrients 2021;13:2674. [PMID: 34444834 DOI: 10.3390/nu13082674] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 To KK, Tong CW, Wu M, Cho WC. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside. World J Gastroenterol 2018; 24(27): 2949-2973 [PMID: 30038463 DOI: 10.3748/wjg.v24.i27.2949] [Cited by in CrossRef: 67] [Cited by in F6Publishing: 67] [Article Influence: 16.8] [Reference Citation Analysis]
4 Wu S, Sun C, Li Y, Wang T, Jia L, Lai S, Yang Y, Luo P, Dai D, Yang YQ, Luo Q, Gao NL, Ning K, He LJ, Zhao XM, Chen WH. GMrepo: a database of curated and consistently annotated human gut metagenomes. Nucleic Acids Res 2020;48:D545-53. [PMID: 31504765 DOI: 10.1093/nar/gkz764] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 11.0] [Reference Citation Analysis]
5 von Frieling J, Fink C, Hamm J, Klischies K, Forster M, Bosch TCG, Roeder T, Rosenstiel P, Sommer F. Grow With the Challenge - Microbial Effects on Epithelial Proliferation, Carcinogenesis, and Cancer Therapy. Front Microbiol 2018;9:2020. [PMID: 30294304 DOI: 10.3389/fmicb.2018.02020] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
6 Yao X, Lan Z, Lai Q, Li A, Liu S, Wang X. LncRNA SNHG6 plays an oncogenic role in colorectal cancer and can be used as a prognostic biomarker for solid tumors. J Cell Physiol 2020;235:7620-34. [PMID: 32239696 DOI: 10.1002/jcp.29672] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
7 Kumari R, Sunil D. Emerging trends in aggregation induced emissive luminogens as bacterial theranostics. J Drug Target 2021;29:793-807. [PMID: 33583291 DOI: 10.1080/1061186X.2021.1888111] [Reference Citation Analysis]
8 Galan-Ros J, Ramos-Arenas V, Conesa-Zamora P. Predictive values of colon microbiota in the treatment response to colorectal cancer. Pharmacogenomics 2020;21:1045-59. [PMID: 32896201 DOI: 10.2217/pgs-2020-0044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Dahiya DK, Renuka. The gut virome: a neglected actor in colon cancer pathogenesis. Future Microbiol 2017;12:1345-8. [PMID: 28952375 DOI: 10.2217/fmb-2017-0159] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
10 Kang M, Zhou C, Wu S, Yu B, Zhang Z, Song N, Lee MMS, Xu W, Xu FJ, Wang D, Wang L, Tang BZ. Evaluation of Structure-Function Relationships of Aggregation-Induced Emission Luminogens for Simultaneous Dual Applications of Specific Discrimination and Efficient Photodynamic Killing of Gram-Positive Bacteria. J Am Chem Soc 2019;141:16781-9. [PMID: 31553608 DOI: 10.1021/jacs.9b07162] [Cited by in Crossref: 108] [Cited by in F6Publishing: 88] [Article Influence: 36.0] [Reference Citation Analysis]
11 Deng X, Li Z, Li G, Li B, Jin X, Lyu G. Comparison of Microbiota in Patients Treated by Surgery or Chemotherapy by 16S rRNA Sequencing Reveals Potential Biomarkers for Colorectal Cancer Therapy. Front Microbiol. 2018;9:1607. [PMID: 30065719 DOI: 10.3389/fmicb.2018.01607] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 7.3] [Reference Citation Analysis]
12 Ramos A, Hemann MT. Drugs, Bugs, and Cancer: Fusobacterium nucleatum Promotes Chemoresistance in Colorectal Cancer. Cell 2017;170:411-3. [PMID: 28753421 DOI: 10.1016/j.cell.2017.07.018] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 5.6] [Reference Citation Analysis]
13 Huang X, Zhu X, Yu Y, Zhu W, Jin L, Zhang X, Li S, Zou P, Xie C, Cui R. Dissecting miRNA signature in colorectal cancer progression and metastasis. Cancer Lett 2021;501:66-82. [PMID: 33385486 DOI: 10.1016/j.canlet.2020.12.025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Milani C, Alessandri G, Mangifesta M, Mancabelli L, Lugli GA, Fontana F, Longhi G, Anzalone R, Viappiani A, Duranti S, Turroni F, Costi R, Annicchiarico A, Morini A, Sarli L, Ossiprandi MC, van Sinderen D, Ventura M. Untangling Species-Level Composition of Complex Bacterial Communities through a Novel Metagenomic Approach. mSystems 2020;5:e00404-20. [PMID: 32723792 DOI: 10.1128/mSystems.00404-20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Velikova T, Krastev B, Lozenov S, Gencheva R, Peshevska-Sekulovska M, Nikolaev G, Peruhova M. Antibiotic-Related Changes in Microbiome: The Hidden Villain behind Colorectal Carcinoma Immunotherapy Failure. Int J Mol Sci 2021;22:1754. [PMID: 33578709 DOI: 10.3390/ijms22041754] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Li Y, Yang P, Zhao L, Chen Y, Zhang X, Zeng S, Wei L, Varghese Z, Moorhead JF, Chen Y, Ruan XZ. CD36 plays a negative role in the regulation of lipophagy in hepatocytes through an AMPK-dependent pathway. J Lipid Res 2019;60:844-55. [PMID: 30662007 DOI: 10.1194/jlr.M090969] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
17 Moghimipour E, Abedishirehjin S, Baghbadorani MA, Handali S. Bacteria and Archaea: A new era of cancer therapy. J Control Release 2021;338:1-7. [PMID: 34391833 DOI: 10.1016/j.jconrel.2021.08.019] [Reference Citation Analysis]
18 Teng NMY, Price CA, McKee AM, Hall LJ, Robinson SD. Exploring the impact of gut microbiota and diet on breast cancer risk and progression. Int J Cancer 2021;149:494-504. [PMID: 33521932 DOI: 10.1002/ijc.33496] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
19 Gaines S, Shao C, Hyman N, Alverdy JC. Gut microbiome influences on anastomotic leak and recurrence rates following colorectal cancer surgery. Br J Surg. 2018;105:e131-e141. [PMID: 29341151 DOI: 10.1002/bjs.10760] [Cited by in Crossref: 60] [Cited by in F6Publishing: 44] [Article Influence: 15.0] [Reference Citation Analysis]
20 Zhang Y, Jiang W, Xu J, Wu N, Wang Y, Lin T, Liu Y, Liu Y. E. coli NF73-1 Isolated From NASH Patients Aggravates NAFLD in Mice by Translocating Into the Liver and Stimulating M1 Polarization. Front Cell Infect Microbiol 2020;10:535940. [PMID: 33363046 DOI: 10.3389/fcimb.2020.535940] [Reference Citation Analysis]
21 Koi M, Okita Y, Carethers JM. Fusobacterium nucleatum Infection in Colorectal Cancer: Linking Inflammation, DNA Mismatch Repair and Genetic and Epigenetic Alterations. J Anus Rectum Colon 2018;2:37-46. [PMID: 30116794 DOI: 10.23922/jarc.2017-055] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
22 Lauka L, Reitano E, Carra MC, Gaiani F, Gavriilidis P, Brunetti F, de'Angelis GL, Sobhani I, de'Angelis N. Role of the intestinal microbiome in colorectal cancer surgery outcomes. World J Surg Oncol 2019;17:204. [PMID: 31791356 DOI: 10.1186/s12957-019-1754-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
23 Wilmanski T, Rappaport N, Diener C, Gibbons SM, Price ND. From taxonomy to metabolic output: what factors define gut microbiome health? Gut Microbes 2021;13:1-20. [PMID: 33890557 DOI: 10.1080/19490976.2021.1907270] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Cheng H, Wang Z, Cui L, Wen Y, Chen X, Gong F, Yi H. Opportunities and Challenges of the Human Microbiome in Ovarian Cancer. Front Oncol 2020;10:163. [PMID: 32133297 DOI: 10.3389/fonc.2020.00163] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
25 Zhou Z, Ge S, Li Y, Ma W, Liu Y, Hu S, Zhang R, Ma Y, Du K, Syed A, Chen P. Human Gut Microbiome-Based Knowledgebase as a Biomarker Screening Tool to Improve the Predicted Probability for Colorectal Cancer. Front Microbiol 2020;11:596027. [PMID: 33329482 DOI: 10.3389/fmicb.2020.596027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Zhang X, Yu L, Shi J, Li S, Yang S, Gao W, Yang S, Cheng M, Wang H, Guo Z, Geng C. Antibiotics modulate neoadjuvant therapy efficiency in patients with breast cancer: a pilot analysis. Sci Rep 2021;11:14024. [PMID: 34234229 DOI: 10.1038/s41598-021-93428-w] [Reference Citation Analysis]
27 Van Zuylen EM, Ferguson SA, Hughes A, Rennison D, Brimble MA, Cook GM. Disruption of Metallostasis in the Anaerobic Human Pathogen Fusobacterium nucleatum by the Zinc Ionophore PBT2. ACS Infect Dis 2021;7:2285-98. [PMID: 34259502 DOI: 10.1021/acsinfecdis.0c00887] [Reference Citation Analysis]
28 Song H, Wang W, Shen B, Jia H, Hou Z, Chen P, Sun Y. Pretreatment with probiotic Bifico ameliorates colitis-associated cancer in mice: Transcriptome and gut flora profiling. Cancer Sci 2018;109:666-77. [PMID: 29288512 DOI: 10.1111/cas.13497] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 9.8] [Reference Citation Analysis]
29 Stasiewicz M, Karpiński TM. The oral microbiota and its role in carcinogenesis. Semin Cancer Biol 2021:S1044-579X(21)00269-8. [PMID: 34743032 DOI: 10.1016/j.semcancer.2021.11.002] [Reference Citation Analysis]
30 Rezasoltani S, Ghanbari R, Looha MA, Mojarad EN, Yadegar A, Stewart D, Aghdaei HA, Zali MR. Expression of Main Toll-Like Receptors in Patients with Different Types of Colorectal Polyps and Their Relationship with Gut Microbiota. Int J Mol Sci 2020;21:E8968. [PMID: 33255933 DOI: 10.3390/ijms21238968] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Kim J, Lee HK. The Role of Gut Microbiota in Modulating Tumor Growth and Anticancer Agent Efficacy. Mol Cells 2021;44:356-62. [PMID: 33972463 DOI: 10.14348/molcells.2021.0032] [Reference Citation Analysis]
32 Chau J, Yadav M, Liu B, Furqan M, Dai Q, Shahi S, Gupta A, Mercer KN, Eastman E, Hejleh TA, Chan C, Weiner GJ, Cherwin C, Lee STM, Zhong C, Mangalam A, Zhang J. Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer. BMC Cancer 2021;21:808. [PMID: 34256732 DOI: 10.1186/s12885-021-08530-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Del Pozo-Acebo L, López de Las Hazas MC, Margollés A, Dávalos A, García-Ruiz A. Eating microRNAs: pharmacological opportunities for cross-kingdom regulation and implications in host gene and gut microbiota modulation. Br J Pharmacol 2021;178:2218-45. [PMID: 33644849 DOI: 10.1111/bph.15421] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
34 Taghinezhad-S S, Mohseni AH, Fu X. Intervention on gut microbiota may change the strategy for management of colorectal cancer. J Gastroenterol Hepatol 2021;36:1508-17. [PMID: 33295040 DOI: 10.1111/jgh.15369] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Du R, Zhao P, Wu S, Gao Y, Wu R, Yang M, Song W, Gao H. Sendeng-4 Suppressed Melanoma Growth by Induction of Autophagy and Apoptosis. Evid Based Complement Alternat Med 2021;2021:5519973. [PMID: 34475961 DOI: 10.1155/2021/5519973] [Reference Citation Analysis]
36 Parhi L, Alon-Maimon T, Sol A, Nejman D, Shhadeh A, Fainsod-Levi T, Yajuk O, Isaacson B, Abed J, Maalouf N, Nissan A, Sandbank J, Yehuda-Shnaidman E, Ponath F, Vogel J, Mandelboim O, Granot Z, Straussman R, Bachrach G. Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression. Nat Commun 2020;11:3259. [PMID: 32591509 DOI: 10.1038/s41467-020-16967-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 18.0] [Reference Citation Analysis]
37 Bao Y, Tang J, Qian Y, Sun T, Chen H, Chen Z, Sun D, Zhong M, Chen H, Hong J, Chen Y, Fang JY. Long noncoding RNA BFAL1 mediates enterotoxigenic Bacteroides fragilis-related carcinogenesis in colorectal cancer via the RHEB/mTOR pathway. Cell Death Dis 2019;10:675. [PMID: 31515468 DOI: 10.1038/s41419-019-1925-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
38 Sepich-poore GD, Zitvogel L, Straussman R, Hasty J, Wargo JA, Knight R. The microbiome and human cancer. Science 2021;371:eabc4552. [DOI: 10.1126/science.abc4552] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 27.0] [Reference Citation Analysis]
39 Yang W, Chen CH, Jia M, Xing X, Gao L, Tsai HT, Zhang Z, Liu Z, Zeng B, Yeung SJ, Lee MH, Cheng C. Tumor-Associated Microbiota in Esophageal Squamous Cell Carcinoma. Front Cell Dev Biol 2021;9:641270. [PMID: 33681225 DOI: 10.3389/fcell.2021.641270] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
40 Lamprinaki D, Garcia-Vello P, Marchetti R, Hellmich C, McCord KA, Bowles KM, Macauley MS, Silipo A, De Castro C, Crocker PR, Juge N. Siglec-7 Mediates Immunomodulation by Colorectal Cancer-Associated Fusobacterium nucleatum ssp. animalis. Front Immunol 2021;12:744184. [PMID: 34659241 DOI: 10.3389/fimmu.2021.744184] [Reference Citation Analysis]
41 Wang Y, Zhang Y, Qian Y, Xie YH, Jiang SS, Kang ZR, Chen YX, Chen ZF, Fang JY. Alterations in the oral and gut microbiome of colorectal cancer patients and association with host clinical factors. Int J Cancer 2021. [PMID: 33844851 DOI: 10.1002/ijc.33596] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Li J, Ma X, Chakravarti D, Shalapour S, DePinho RA. Genetic and biological hallmarks of colorectal cancer. Genes Dev 2021;35:787-820. [PMID: 34074695 DOI: 10.1101/gad.348226.120] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Cao Y, Liu H, Qin N, Ren X, Zhu B, Xia X. Impact of food additives on the composition and function of gut microbiota: A review. Trends in Food Science & Technology 2020;99:295-310. [DOI: 10.1016/j.tifs.2020.03.006] [Cited by in Crossref: 29] [Cited by in F6Publishing: 14] [Article Influence: 14.5] [Reference Citation Analysis]
44 Fu MM, Chien WC, Chung CH, Lee WC, Tu HP, Fu E. Is periodontitis a risk factor of benign or malignant colorectal tumor? A population-based cohort study. J Periodontal Res 2021. [PMID: 34854493 DOI: 10.1111/jre.12955] [Reference Citation Analysis]
45 Zhang P, Gao D, An K, Shen Q, Wang C, Zhang Y, Pan X, Chen X, Lyv Y, Cui C, Liang T, Duan X, Liu J, Yang T, Hu X, Zhu J, Xu F, Tan W. A programmable polymer library that enables the construction of stimuli-responsive nanocarriers containing logic gates. Nat Chem 2020;12:381-90. [DOI: 10.1038/s41557-020-0426-3] [Cited by in Crossref: 36] [Cited by in F6Publishing: 22] [Article Influence: 18.0] [Reference Citation Analysis]
46 Shuwen H, Xi Y, Quan Q, Yuefen P, Miao D, Qing Z. Relationship between intestinal microorganisms and T lymphocytes in colorectal cancer. Future Oncol. 2019;15:1655-1666. [PMID: 31044617 DOI: 10.2217/fon-2018-0595] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
47 Villar-Ortega P, Expósito-Ruiz M, Gutiérrez-Soto M, Ruiz-Cabello Jiménez M, Navarro-Marí JM, Gutiérrez-Fernández J. The association between Fusobacterium nucleatum and cancer colorectal: a systematic review and meta-analysis. Enferm Infecc Microbiol Clin (Engl Ed) 2021:S0213-005X(21)00026-4. [PMID: 33632539 DOI: 10.1016/j.eimc.2021.01.005] [Reference Citation Analysis]
48 Jobin C. Bacterial snack attack deactivates a drug. Nature 2017;550:337-9. [DOI: 10.1038/550337a] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
49 Bartolini I, Risaliti M, Ringressi MN, Melli F, Nannini G, Amedei A, Muiesan P, Taddei A. Role of gut microbiota-immunity axis in patients undergoing surgery for colorectal cancer: Focus on short and long-term outcomes. World J Gastroenterol 2020; 26(20): 2498-2513 [PMID: 32523307 DOI: 10.3748/wjg.v26.i20.2498] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
50 Koulouris A, Tsagkaris C, Messaritakis I, Gouvas N, Sfakianaki M, Trypaki M, Spyrou V, Christodoulakis M, Athanasakis E, Xynos E, Tzardi M, Mavroudis D, Souglakos J. Resectable Colorectal Cancer: Current Perceptions on the Correlation of Recurrence Risk, Microbiota and Detection of Genetic Mutations in Liquid Biopsies. Cancers (Basel) 2021;13:3522. [PMID: 34298740 DOI: 10.3390/cancers13143522] [Reference Citation Analysis]
51 Chen DP, Ning WR, Li XF, Wei Y, Lao XM, Wang JC, Wu Y, Zheng L. Peritumoral monocytes induce cancer cell autophagy to facilitate the progression of human hepatocellular carcinoma. Autophagy 2018;14:1335-46. [PMID: 29940792 DOI: 10.1080/15548627.2018.1474994] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 6.5] [Reference Citation Analysis]
52 Chattopadhyay I, Dhar R, Pethusamy K, Seethy A, Srivastava T, Sah R, Sharma J, Karmakar S. Exploring the Role of Gut Microbiome in Colon Cancer. Appl Biochem Biotechnol 2021;193:1780-99. [PMID: 33492552 DOI: 10.1007/s12010-021-03498-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
53 You XH, Wen C, Xia ZJ, Sun F, Li Y, Wang W, Fang Z, Chen QG, Zhang L, Jiang YH, Wang XZ, Ying HQ, Zong Z. Primary Tumor Sidedness Predicts Bevacizumab Benefit in Metastatic Colorectal Cancer Patients. Front Oncol 2019;9:723. [PMID: 31475100 DOI: 10.3389/fonc.2019.00723] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
54 Cheng Y, Ling Z, Li L. The Intestinal Microbiota and Colorectal Cancer. Front Immunol 2020;11:615056. [PMID: 33329610 DOI: 10.3389/fimmu.2020.615056] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
55 Kitamoto S, Nagao-Kitamoto H, Hein R, Schmidt TM, Kamada N. The Bacterial Connection between the Oral Cavity and the Gut Diseases. J Dent Res 2020;99:1021-9. [PMID: 32464078 DOI: 10.1177/0022034520924633] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
56 Brennan CA, Clay SL, Lavoie SL, Bae S, Lang JK, Fonseca-Pereira D, Rosinski KG, Ou N, Glickman JN, Garrett WS. Fusobacterium nucleatum drives a pro-inflammatory intestinal microenvironment through metabolite receptor-dependent modulation of IL-17 expression. Gut Microbes 2021;13:1987780. [PMID: 34781821 DOI: 10.1080/19490976.2021.1987780] [Reference Citation Analysis]
57 Deng Y, Yao H, Chen W, Wei H, Li X, Zhang F, Gao S, Man H, Chen J, Tao X, Li M, Chen W. Profiling of polar urine metabolite extracts from Chinese colorectal cancer patients to screen for potential diagnostic and adverse-effect biomarkers. J Cancer 2020;11:6925-38. [PMID: 33123283 DOI: 10.7150/jca.47631] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
58 Zella D, Gallo RC. Viruses and Bacteria Associated with Cancer: An Overview. Viruses 2021;13:1039. [PMID: 34072757 DOI: 10.3390/v13061039] [Reference Citation Analysis]
59 Li P, Shu Y, Gu Y. The potential role of bacteria in pancreatic cancer: a systematic review. Carcinogenesis. 2020;41:397-404. [PMID: 32034405 DOI: 10.1093/carcin/bgaa013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
60 Oliva M, Mulet-Margalef N, Ochoa-De-Olza M, Napoli S, Mas J, Laquente B, Alemany L, Duell EJ, Nuciforo P, Moreno V. Tumor-Associated Microbiome: Where Do We Stand? Int J Mol Sci 2021;22:1446. [PMID: 33535583 DOI: 10.3390/ijms22031446] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Cui Z, Zhang Y, Xia K, Yan Q, Kong H, Zhang J, Zuo X, Shi J, Wang L, Zhu Y, Fan C. Nanodiamond autophagy inhibitor allosterically improves the arsenical-based therapy of solid tumors. Nat Commun 2018;9:4347. [PMID: 30341298 DOI: 10.1038/s41467-018-06749-2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 8.8] [Reference Citation Analysis]
62 Araujo DV, Watson GA, Oliva M, Heirali A, Coburn B, Spreafico A, Siu LL. Bugs as drugs: The role of microbiome in cancer focusing on immunotherapeutics. Cancer Treat Rev 2021;92:102125. [PMID: 33227623 DOI: 10.1016/j.ctrv.2020.102125] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
63 Kaźmierczak-Siedlecka K, Ruszkowski J, Skonieczna-Żydecka K, Jędrzejczak J, Folwarski M, Makarewicz W. Gastrointestinal cancers: the role of microbiota in carcinogenesis and the role of probiotics and microbiota in anti-cancer therapy efficacy. Cent Eur J Immunol 2020;45:476-87. [PMID: 33658894 DOI: 10.5114/ceji.2020.103353] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Han M, Hu J, Lu P, Cao H, Yu C, Li X, Qian X, Yang X, Yang Y, Han N, Dou D, Zhang F, Ye M, Yang C, Gu Y, Dong H. Exosome-transmitted miR-567 reverses trastuzumab resistance by inhibiting ATG5 in breast cancer. Cell Death Dis 2020;11:43. [PMID: 31969559 DOI: 10.1038/s41419-020-2250-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 17.0] [Reference Citation Analysis]
65 Hajishengallis G, Chavakis T. Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities. Nat Rev Immunol 2021;21:426-40. [PMID: 33510490 DOI: 10.1038/s41577-020-00488-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 18.0] [Reference Citation Analysis]
66 Qiu L, Hu L, Wang H, Li J, Ruan X, Sun B, Zhi J, Zheng X, Gu L, Gao M, Kong P, Zhang J. FATS regulates polyamine biosynthesis by promoting ODC degradation in an ERβ-dependent manner in non-small-cell lung cancer. Cell Death Dis 2020;11:839. [PMID: 33037185 DOI: 10.1038/s41419-020-03052-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
67 Lu H, Shi T, Wang M, Li X, Gu Y, Zhang X, Zhang G, Chen W. B7-H3 inhibits the IFN-γ-dependent cytotoxicity of Vγ9Vδ2 T cells against colon cancer cells. Oncoimmunology 2020;9:1748991. [PMID: 32363121 DOI: 10.1080/2162402X.2020.1748991] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
68 Zhao Z, Liu M, Long W, Yuan J, Li H, Zhang C, Tang G, Jiang W, Yuan X, Wu M, Liu Q. Knockdown lncRNA CRNDE enhances temozolomide chemosensitivity by regulating autophagy in glioblastoma. Cancer Cell Int 2021;21:456. [PMID: 34454479 DOI: 10.1186/s12935-021-02153-x] [Reference Citation Analysis]
69 Jiang Z, Li L, Chen J, Wei G, Ji Y, Chen X, Liu J, Huo J. Human gut-microbiome interplay: Analysis of clinical studies for the emerging roles of diagnostic microbiology in inflammation, oncogenesis and cancer management. Infect Genet Evol 2021;93:104946. [PMID: 34052417 DOI: 10.1016/j.meegid.2021.104946] [Reference Citation Analysis]
70 Poland JC, Flynn CR. Bile Acids, Their Receptors, and the Gut Microbiota. Physiology (Bethesda) 2021;36:235-45. [PMID: 34159805 DOI: 10.1152/physiol.00028.2020] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Leystra AA, Clapper ML. Gut Microbiota Influences Experimental Outcomes in Mouse Models of Colorectal Cancer. Genes (Basel). 2019;10. [PMID: 31703321 DOI: 10.3390/genes10110900] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
72 Sharma M, Li Y, Stoll ML, Tollefsbol TO. The Epigenetic Connection Between the Gut Microbiome in Obesity and Diabetes. Front Genet 2019;10:1329. [PMID: 32010189 DOI: 10.3389/fgene.2019.01329] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 13.5] [Reference Citation Analysis]
73 Routy B, Gopalakrishnan V, Daillère R, Zitvogel L, Wargo JA, Kroemer G. The gut microbiota influences anticancer immunosurveillance and general health. Nat Rev Clin Oncol 2018;15:382-96. [PMID: 29636538 DOI: 10.1038/s41571-018-0006-2] [Cited by in Crossref: 167] [Cited by in F6Publishing: 152] [Article Influence: 55.7] [Reference Citation Analysis]
74 Pacheco Y, Lim CX, Weichhart T, Valeyre D, Bentaher A, Calender A. Sarcoidosis and the mTOR, Rac1, and Autophagy Triad. Trends Immunol 2020;41:286-99. [PMID: 32122794 DOI: 10.1016/j.it.2020.01.007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
75 Handsley-Davis M, Jamieson L, Kapellas K, Hedges J, Weyrich LS. The role of the oral microbiota in chronic non-communicable disease and its relevance to the Indigenous health gap in Australia. BMC Oral Health 2020;20:327. [PMID: 33198712 DOI: 10.1186/s12903-020-01308-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 Mihai MM, Ion A, Giurcăneanu C, Nițipir C, Popa AM, Chifiriuc MC, Popa MI, Říčař J, Popa LG, Sârbu I, Lazăr V. The Impact of Long-Term Antibiotic Therapy of Cutaneous Adverse Reactions to EGFR Inhibitors in Colorectal Cancer Patients. J Clin Med 2021;10:3219. [PMID: 34362003 DOI: 10.3390/jcm10153219] [Reference Citation Analysis]
77 Wang M, Han D, Yuan Z, Hu H, Zhao Z, Yang R, Jin Y, Zou C, Chen Y, Wang G, Gao X, Wang X. Long non-coding RNA H19 confers 5-Fu resistance in colorectal cancer by promoting SIRT1-mediated autophagy. Cell Death Dis. 2018;9:1149. [PMID: 30451820 DOI: 10.1038/s41419-018-1187-4] [Cited by in Crossref: 64] [Cited by in F6Publishing: 68] [Article Influence: 16.0] [Reference Citation Analysis]
78 Su W, Chen Y, Cao P, Chen Y, Guo Y, Wang S, Dong W. Fusobacterium nucleatum Promotes the Development of Ulcerative Colitis by Inducing the Autophagic Cell Death of Intestinal Epithelial. Front Cell Infect Microbiol 2020;10:594806. [PMID: 33330137 DOI: 10.3389/fcimb.2020.594806] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
79 Alexander JL, Kohoutova D, Powell N. Science in Focus: The Microbiome and Cancer Therapy. Clin Oncol (R Coll Radiol) 2019;31:1-4. [PMID: 30301591 DOI: 10.1016/j.clon.2018.09.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
80 Fidelle M, Yonekura S, Picard M, Cogdill A, Hollebecque A, Roberti MP, Zitvogel L. Resolving the Paradox of Colon Cancer Through the Integration of Genetics, Immunology, and the Microbiota. Front Immunol 2020;11:600886. [PMID: 33381121 DOI: 10.3389/fimmu.2020.600886] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
81 Zhao MF, Liang GD, Zhou YJ, Chi ZP, Zhuang H, Zhu SL, Wang Y, Liu GR, Zhao JB, Liu SL. Novel Bacillus strains from the human gut exert anticancer effects on a broad range of malignancy types. Invest New Drugs 2020;38:1373-82. [PMID: 32734371 DOI: 10.1007/s10637-020-00906-5] [Reference Citation Analysis]
82 Borgognone A, Serna G, Noguera-Julian M, Alonso L, Parera M, Català-Moll F, Sanchez L, Fasani R, Paredes R, Nuciforo P. Performance of 16S Metagenomic Profiling in Formalin-Fixed Paraffin-Embedded versus Fresh-Frozen Colorectal Cancer Tissues. Cancers (Basel) 2021;13:5421. [PMID: 34771584 DOI: 10.3390/cancers13215421] [Reference Citation Analysis]
83 Kabwe M, Brown TL, Dashper S, Speirs L, Ku H, Petrovski S, Chan HT, Lock P, Tucci J. Genomic, morphological and functional characterisation of novel bacteriophage FNU1 capable of disrupting Fusobacterium nucleatum biofilms. Sci Rep 2019;9:9107. [PMID: 31235721 DOI: 10.1038/s41598-019-45549-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
84 Xu JY, Liu MT, Tao T, Zhu X, Fei FQ. The role of gut microbiota in tumorigenesis and treatment. Biomed Pharmacother 2021;138:111444. [PMID: 33662679 DOI: 10.1016/j.biopha.2021.111444] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
85 Zhou L, Gao W, Wang K, Huang Z, Zhang L, Zhang Z, Zhou J, Nice EC, Huang C. Brefeldin A inhibits colorectal cancer growth by triggering Bip/Akt-regulated autophagy. FASEB J 2019;33:5520-34. [PMID: 30668917 DOI: 10.1096/fj.201801983R] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
86 Chen Y, Chen YX. Microbiota-Associated Metabolites and Related Immunoregulation in Colorectal Cancer. Cancers (Basel) 2021;13:4054. [PMID: 34439208 DOI: 10.3390/cancers13164054] [Reference Citation Analysis]
87 Illescas O, Rodríguez-Sosa M, Gariboldi M. Mediterranean Diet to Prevent the Development of Colon Diseases: A Meta-Analysis of Gut Microbiota Studies. Nutrients 2021;13:2234. [PMID: 34209683 DOI: 10.3390/nu13072234] [Reference Citation Analysis]
88 Li G, Kong B, Tong Q, Li Y, Chen L, Zeng J, Yu H, Xie X, Zhang J. Vanillin downregulates NNMT and attenuates NNMT‑related resistance to 5‑fluorouracil via ROS‑induced cell apoptosis in colorectal cancer cells. Oncol Rep 2021;45:110. [PMID: 33907844 DOI: 10.3892/or.2021.8061] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Song W, Tiruthani K, Wang Y, Shen L, Hu M, Dorosheva O, Qiu K, Kinghorn KA, Liu R, Huang L. Trapping of Lipopolysaccharide to Promote Immunotherapy against Colorectal Cancer and Attenuate Liver Metastasis. Adv Mater 2018;30:e1805007. [PMID: 30387230 DOI: 10.1002/adma.201805007] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 14.3] [Reference Citation Analysis]
90 Crudele F, Bianchi N, Astolfi A, Grassilli S, Brugnoli F, Terrazzan A, Bertagnolo V, Negrini M, Frassoldati A, Volinia S. The Molecular Networks of microRNAs and Their Targets in the Drug Resistance of Colon Carcinoma. Cancers (Basel) 2021;13:4355. [PMID: 34503164 DOI: 10.3390/cancers13174355] [Reference Citation Analysis]
91 Wang X, Yang C, Zhao Y, Xu Z, Yang W, Wang P, Lin D, Xiong B, Fang J, Dong C, Zhong B. The deubiquitinase USP25 supports colonic inflammation and bacterial infection and promotes colorectal cancer. Nat Cancer 2020;1:811-25. [DOI: 10.1038/s43018-020-0089-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Wang H, Wang X, Zhang H, Deng T, Liu R, Liu Y, Li H, Bai M, Ning T, Wang J, Ge S, Ba Y. The HSF1/miR-135b-5p axis induces protective autophagy to promote oxaliplatin resistance through the MUL1/ULK1 pathway in colorectal cancer. Oncogene 2021;40:4695-708. [PMID: 34140641 DOI: 10.1038/s41388-021-01898-z] [Reference Citation Analysis]
93 Pavel FM, Vesa CM, Gheorghe G, Diaconu CC, Stoicescu M, Munteanu MA, Babes EE, Tit DM, Toma MM, Bungau S. Highlighting the Relevance of Gut Microbiota Manipulation in Inflammatory Bowel Disease. Diagnostics (Basel) 2021;11:1090. [PMID: 34203609 DOI: 10.3390/diagnostics11061090] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
94 Sayed IM, Chakraborty A, Abd El-Hafeez AA, Sharma A, Sahan AZ, Huang WJM, Sahoo D, Ghosh P, Hazra TK, Das S. The DNA Glycosylase NEIL2 Suppresses Fusobacterium-Infection-Induced Inflammation and DNA Damage in Colonic Epithelial Cells. Cells 2020;9:E1980. [PMID: 32872214 DOI: 10.3390/cells9091980] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
95 Feng Y, Huang Y, Wang Y, Wang P, Song H, Wang F. Antibiotics induced intestinal tight junction barrier dysfunction is associated with microbiota dysbiosis, activated NLRP3 inflammasome and autophagy. PLoS One 2019;14:e0218384. [PMID: 31211803 DOI: 10.1371/journal.pone.0218384] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 13.0] [Reference Citation Analysis]
96 Prattichizzo F, Giuliani A, Mensà E, Sabbatinelli J, De Nigris V, Rippo MR, La Sala L, Procopio AD, Olivieri F, Ceriello A. Pleiotropic effects of metformin: Shaping the microbiome to manage type 2 diabetes and postpone ageing. Ageing Res Rev 2018;48:87-98. [PMID: 30336272 DOI: 10.1016/j.arr.2018.10.003] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 11.0] [Reference Citation Analysis]
97 Qin Y, Wade PA. Crosstalk between the microbiome and epigenome: messages from bugs. J Biochem 2018;163:105-12. [PMID: 29161429 DOI: 10.1093/jb/mvx080] [Cited by in Crossref: 88] [Cited by in F6Publishing: 78] [Article Influence: 22.0] [Reference Citation Analysis]
98 Appunni S, Rubens M, Ramamoorthy V, Tonse R, Saxena A, McGranaghan P, Kaiser A, Kotecha R. Emerging Evidence on the Effects of Dietary Factors on the Gut Microbiome in Colorectal Cancer. Front Nutr 2021;8:718389. [PMID: 34708063 DOI: 10.3389/fnut.2021.718389] [Reference Citation Analysis]
99 Tam C, Rao S, Waye MMY, Ng TB, Wang CC. Autophagy signals orchestrate chemoresistance of gynecological cancers. Biochim Biophys Acta Rev Cancer 2021;1875:188525. [PMID: 33600824 DOI: 10.1016/j.bbcan.2021.188525] [Reference Citation Analysis]
100 Liu R, Zhong Y, Chen R, Chen S, Huang Y, Liu H. Bacterial infections exacerbate myeloma bone disease. J Transl Med 2022;20:16. [PMID: 34991592 DOI: 10.1186/s12967-021-03187-5] [Reference Citation Analysis]
101 Wu C, Al Mamun AAM, Luong TT, Hu B, Gu J, Lee JH, D'Amore M, Das A, Ton-That H. Forward Genetic Dissection of Biofilm Development by Fusobacterium nucleatum: Novel Functions of Cell Division Proteins FtsX and EnvC. mBio 2018;9:e00360-18. [PMID: 29691334 DOI: 10.1128/mBio.00360-18] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
102 Harrandah AM, Chukkapalli SS, Bhattacharyya I, Progulske-Fox A, Chan EKL. Fusobacteria modulate oral carcinogenesis and promote cancer progression. J Oral Microbiol 2020;13:1849493. [PMID: 33391626 DOI: 10.1080/20002297.2020.1849493] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
103 Greten FR, Grivennikov SI. Inflammation and Cancer: Triggers, Mechanisms, and Consequences. Immunity. 2019;51:27-41. [PMID: 31315034 DOI: 10.1016/j.immuni.2019.06.025] [Cited by in Crossref: 335] [Cited by in F6Publishing: 347] [Article Influence: 111.7] [Reference Citation Analysis]
104 Patel A, Spychalski P, Antoszewska M, Regula J, Kobiela J. Proton pump inhibitors and colorectal cancer: A systematic review. World J Gastroenterol 2021; 27(44): 7716-7733 [PMID: 34908809 DOI: 10.3748/wjg.v27.i44.7716] [Reference Citation Analysis]
105 Kroemer G, Zitvogel L. Cancer immunotherapy in 2017: The breakthrough of the microbiota. Nat Rev Immunol 2018;18:87-8. [PMID: 29379189 DOI: 10.1038/nri.2018.4] [Cited by in Crossref: 64] [Cited by in F6Publishing: 56] [Article Influence: 21.3] [Reference Citation Analysis]
106 Zhang N, Zhang X, Xu W, Zhang X, Mu Z. CircRNA_103948 inhibits autophagy in colorectal cancer in a ceRNA manner. Ann N Y Acad Sci 2021. [PMID: 34480353 DOI: 10.1111/nyas.14679] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
107 Sayed IM, Ramadan HK, El-mokhtar MA, Abdel-wahid L. Microbiome and gastrointestinal malignancies. Current Opinion in Physiology 2021;22:100451. [DOI: 10.1016/j.cophys.2021.06.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
108 Shen X, Li J, Li J, Zhang Y, Li X, Cui Y, Gao Q, Chen X, Chen Y, Fang JY. Fecal Enterotoxigenic Bacteroides fragilis-Peptostreptococcus stomatis-Parvimonas micra Biomarker for Noninvasive Diagnosis and Prognosis of Colorectal Laterally Spreading Tumor. Front Oncol 2021;11:661048. [PMID: 34046355 DOI: 10.3389/fonc.2021.661048] [Reference Citation Analysis]
109 Li X, Li Q, Yu X, Li H, Huang G. Reverse of microtubule-directed chemotherapeutic drugs resistance induced by cancer-associated fibroblasts in breast cancer. Onco Targets Ther 2019;12:7963-73. [PMID: 31579239 DOI: 10.2147/OTT.S211043] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
110 Wang L, Lo CH, He X, Hang D, Wang M, Wu K, Chan AT, Ogino S, Giovannucci EL, Song M. Risk Factor Profiles Differ for Cancers of Different Regions of the Colorectum. Gastroenterology 2020;159:241-256.e13. [PMID: 32247020 DOI: 10.1053/j.gastro.2020.03.054] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
111 Zhu C, Zhang L, Zhao S, Dai W, Xu Y, Zhang Y, Zheng H, Sheng W, Xu Y. UPF1 promotes chemoresistance to oxaliplatin through regulation of TOP2A activity and maintenance of stemness in colorectal cancer. Cell Death Dis 2021;12:519. [PMID: 34021129 DOI: 10.1038/s41419-021-03798-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
112 Xia H, Green DR, Zou W. Autophagy in tumour immunity and therapy. Nat Rev Cancer 2021;21:281-97. [PMID: 33758415 DOI: 10.1038/s41568-021-00344-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
113 Chen X, Luo Q, Ding J, Yang M, Zhang R, Chen F. Zymosan promotes proliferation, Candida albicans adhesion and IL-1β production of oral squamous cell carcinoma in vitro. Infect Agent Cancer 2020;15:51. [PMID: 32760436 DOI: 10.1186/s13027-020-00315-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
114 Zhang J, Tao J, Gao RN, Wei ZY, He YS, Ren CY, Li QC, Liu YS, Wang KW, Yang G, Qian C, Chen JH. Cytotoxic T-Cell Trafficking Chemokine Profiles Correlate With Defined Mucosal Microbial Communities in Colorectal Cancer. Front Immunol 2021;12:715559. [PMID: 34539647 DOI: 10.3389/fimmu.2021.715559] [Reference Citation Analysis]
115 Dalal P, Sharma D. Microbe defines the efficacy of chemotherapeutic drug: a complete paradigm. FEMS Microbiol Lett 2021;368:fnab116. [PMID: 34448860 DOI: 10.1093/femsle/fnab116] [Reference Citation Analysis]
116 Chen QW, Qiao JY, Liu XH, Zhang C, Zhang XZ. Customized materials-assisted microorganisms in tumor therapeutics. Chem Soc Rev 2021;50:12576-615. [PMID: 34605834 DOI: 10.1039/d0cs01571g] [Reference Citation Analysis]
117 Despins CA, Brown SD, Robinson AV, Mungall AJ, Allen-Vercoe E, Holt RA. Modulation of the Host Cell Transcriptome and Epigenome by Fusobacterium nucleatum. mBio 2021;12:e0206221. [PMID: 34700376 DOI: 10.1128/mBio.02062-21] [Reference Citation Analysis]
118 Duan L, Yang W, Feng W, Cao L, Wang X, Niu L, Li Y, Zhou W, Zhang Y, Liu J, Zhang H, Zhao Q, Hong L, Fan D. Molecular mechanisms and clinical implications of miRNAs in drug resistance of colorectal cancer. Ther Adv Med Oncol 2020;12:1758835920947342. [PMID: 32922521 DOI: 10.1177/1758835920947342] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
119 Pham F, Moinard-Butot F, Coutzac C, Chaput N. Cancer and immunotherapy: a role for microbiota composition. Eur J Cancer 2021;155:145-54. [PMID: 34375896 DOI: 10.1016/j.ejca.2021.06.051] [Reference Citation Analysis]
120 Picardo SL, Coburn B, Hansen AR. The microbiome and cancer for clinicians. Crit Rev Oncol Hematol. 2019;141:1-12. [PMID: 31202124 DOI: 10.1016/j.critrevonc.2019.06.004] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 11.0] [Reference Citation Analysis]
121 Tibbs TN, Lopez LR, Arthur JC. The influence of the microbiota on immune development, chronic inflammation, and cancer in the context of aging. Microb Cell 2019;6:324-34. [PMID: 31403049 DOI: 10.15698/mic2019.08.685] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
122 Hanus M, Parada-Venegas D, Landskron G, Wielandt AM, Hurtado C, Alvarez K, Hermoso MA, López-Köstner F, De la Fuente M. Immune System, Microbiota, and Microbial Metabolites: The Unresolved Triad in Colorectal Cancer Microenvironment. Front Immunol 2021;12:612826. [PMID: 33841394 DOI: 10.3389/fimmu.2021.612826] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
123 Wang Z, Zheng Y, Huang H, He H, Jia Q. [Golgi phosphoprotein 3 overexpression inhibits paclitaxel-induced apoptosis in HeLa cells by promoting autophagy]. Nan Fang Yi Ke Da Xue Xue Bao 2019;39:1280-6. [PMID: 31852648 DOI: 10.12122/j.issn.1673-4254.2019.11.03] [Reference Citation Analysis]
124 Wang Y, Zhang Y, Wang Z, Tang J, Cao DX, Qian Y, Xie YH, Chen HY, Chen YX, Chen ZF, Fang JY. A clinical nomogram incorporating salivary Desulfovibrio desulfuricans level and oral hygiene index for predicting colorectal cancer. Ann Transl Med 2021;9:754. [PMID: 34268367 DOI: 10.21037/atm-20-8168] [Reference Citation Analysis]
125 Chattopadhyay I, Nandi D, Nag A. The pint- sized powerhouse: Illuminating the mighty role of the gut microbiome in improving the outcome of anti- cancer therapy. Semin Cancer Biol 2021;70:98-111. [PMID: 32739479 DOI: 10.1016/j.semcancer.2020.07.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
126 de Souza JB, Brelaz-de-Castro MCA, Cavalcanti IMF. Strategies for the treatment of colorectal cancer caused by gut microbiota. Life Sci 2021;290:120202. [PMID: 34896161 DOI: 10.1016/j.lfs.2021.120202] [Reference Citation Analysis]
127 Wei PL, Hung CS, Kao YW, Lin YC, Lee CY, Chang TH, Shia BC, Lin JC. Classification of Changes in the Fecal Microbiota Associated with Colonic Adenomatous Polyps Using a Long-Read Sequencing Platform. Genes (Basel) 2020;11:E1374. [PMID: 33233735 DOI: 10.3390/genes11111374] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
128 Banfi D, Moro E, Bosi A, Bistoletti M, Cerantola S, Crema F, Maggi F, Giron MC, Giaroni C, Baj A. Impact of Microbial Metabolites on Microbiota-Gut-Brain Axis in Inflammatory Bowel Disease. Int J Mol Sci 2021;22:1623. [PMID: 33562721 DOI: 10.3390/ijms22041623] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
129 Bullman S, Pedamallu CS, Sicinska E, Clancy TE, Zhang X, Cai D, Neuberg D, Huang K, Guevara F, Nelson T, Chipashvili O, Hagan T, Walker M, Ramachandran A, Diosdado B, Serna G, Mulet N, Landolfi S, Ramon Y Cajal S, Fasani R, Aguirre AJ, Ng K, Élez E, Ogino S, Tabernero J, Fuchs CS, Hahn WC, Nuciforo P, Meyerson M. Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer. Science 2017;358:1443-8. [PMID: 29170280 DOI: 10.1126/science.aal5240] [Cited by in Crossref: 436] [Cited by in F6Publishing: 395] [Article Influence: 87.2] [Reference Citation Analysis]
130 Sphyris N, Hodder MC, Sansom OJ. Subversion of Niche-Signalling Pathways in Colorectal Cancer: What Makes and Breaks the Intestinal Stem Cell. Cancers (Basel) 2021;13:1000. [PMID: 33673710 DOI: 10.3390/cancers13051000] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
131 Karpiński TM, Ożarowski M, Stasiewicz M. Carcinogenic microbiota and its role in colorectal cancer development. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.01.004] [Reference Citation Analysis]
132 Liu Y, Kong C, Gong L, Zhang X, Zhu Y, Wang H, Qu X, Gao R, Yin F, Liu X, Qin H. The Association of Post-Stroke Cognitive Impairment and Gut Microbiota and its Corresponding Metabolites. J Alzheimers Dis 2020;73:1455-66. [PMID: 31929168 DOI: 10.3233/JAD-191066] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 12.0] [Reference Citation Analysis]
133 Lawrence GW, Begley M, Cotter PD, Guinane CM. Potential Use of Biotherapeutic Bacteria to Target Colorectal Cancer-Associated Taxa. Int J Mol Sci 2020;21:E924. [PMID: 32019270 DOI: 10.3390/ijms21030924] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
134 Zella D, Curreli S, Benedetti F, Krishnan S, Cocchi F, Latinovic OS, Denaro F, Romerio F, Djavani M, Charurat ME, Bryant JL, Tettelin H, Gallo RC. Mycoplasma promotes malignant transformation in vivo, and its DnaK, a bacterial chaperone protein, has broad oncogenic properties. Proc Natl Acad Sci U S A 2018;115:E12005-14. [PMID: 30509983 DOI: 10.1073/pnas.1815660115] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
135 Villéger R, Lopès A, Carrier G, Veziant J, Billard E, Barnich N, Gagnière J, Vazeille E, Bonnet M. Intestinal Microbiota: A Novel Target to Improve Anti-Tumor Treatment? Int J Mol Sci 2019;20:E4584. [PMID: 31533218 DOI: 10.3390/ijms20184584] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 11.7] [Reference Citation Analysis]
136 Li L, Li X, Zhong W, Yang M, Xu M, Sun Y, Ma J, Liu T, Song X, Dong W, Liu X, Chen Y, Liu Y, Abla Z, Liu W, Wang B, Jiang K, Cao H. Gut microbiota from colorectal cancer patients enhances the progression of intestinal adenoma in Apcmin/+ mice. EBioMedicine. 2019;48:301-315. [PMID: 31594750 DOI: 10.1016/j.ebiom.2019.09.021] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 9.7] [Reference Citation Analysis]
137 Rubbino F, Greco L, di Cristofaro A, Gaiani F, Vetrano S, Laghi L, Bonovas S, Piovani D. Journey through Crohn's Disease Complication: From Fistula Formation to Future Therapies. J Clin Med 2021;10:5548. [PMID: 34884247 DOI: 10.3390/jcm10235548] [Reference Citation Analysis]
138 Liu S, Zeng F, Fan G, Dong Q. Identification of Hub Genes and Construction of a Transcriptional Regulatory Network Associated With Tumor Recurrence in Colorectal Cancer by Weighted Gene Co-expression Network Analysis. Front Genet 2021;12:649752. [PMID: 33897765 DOI: 10.3389/fgene.2021.649752] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
139 Fukuda S, Ito S, Nishikawa J, Takagi T, Kubota N, Otsuyama KI, Tsuneoka H, Nojima J, Harada K, Mishima K, Suehiro Y, Yamasaki T, Sakaida I. Deep Ultraviolet Light-Emitting Diode Light Therapy for Fusobacterium nucleatum. Microorganisms 2021;9:430. [PMID: 33669771 DOI: 10.3390/microorganisms9020430] [Reference Citation Analysis]
140 Baffy G. Gut Microbiota and Cancer of the Host: Colliding Interests. Adv Exp Med Biol 2020;1219:93-107. [PMID: 32130695 DOI: 10.1007/978-3-030-34025-4_5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
141 Petri J, Nakatani Y, Montgomery MG, Ferguson SA, Aragão D, Leslie AGW, Heikal A, Walker JE, Cook GM. Structure of F1-ATPase from the obligate anaerobe Fusobacterium nucleatum. Open Biol 2019;9:190066. [PMID: 31238823 DOI: 10.1098/rsob.190066] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
142 Skoufos G, Kardaras FS, Alexiou A, Kavakiotis I, Lambropoulou A, Kotsira V, Tastsoglou S, Hatzigeorgiou AG. Peryton: a manual collection of experimentally supported microbe-disease associations. Nucleic Acids Res 2021;49:D1328-33. [PMID: 33080028 DOI: 10.1093/nar/gkaa902] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
143 Fong W, Li Q, Yu J. Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer. Oncogene. 2020;39:4925-4943. [PMID: 32514151 DOI: 10.1038/s41388-020-1341-1] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 28.5] [Reference Citation Analysis]
144 Si H, Yang Q, Hu H, Ding C, Wang H, Lin X. Colorectal cancer occurrence and treatment based on changes in intestinal flora. Semin Cancer Biol 2021;70:3-10. [PMID: 32404293 DOI: 10.1016/j.semcancer.2020.05.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
145 Zhao S, Sun M, Meng H, Ji H, Liu Y, Zhang M, Li H, Li P, Zhang Y, Zhang Q. TLR4 expression correlated with PD-L1 expression indicates a poor prognosis in patients with peripheral T-cell lymphomas. Cancer Manag Res 2019;11:4743-56. [PMID: 31191027 DOI: 10.2147/CMAR.S203156] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
146 Yan X, Zhang YL, Zhang L, Zou LX, Chen C, Liu Y, Xia YL, Li HH. Gallic Acid Suppresses Cardiac Hypertrophic Remodeling and Heart Failure. Mol Nutr Food Res 2019;63:e1800807. [PMID: 30521107 DOI: 10.1002/mnfr.201800807] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
147 Li X, Huang J, Yu T, Fang X, Lou L, Xin S, Ji L, Jiang F, Lou Y. Fusobacterium nucleatum Promotes the Progression of Colorectal Cancer Through Cdk5-Activated Wnt/β-Catenin Signaling. Front Microbiol 2020;11:545251. [PMID: 33488528 DOI: 10.3389/fmicb.2020.545251] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
148 Liu Y, Baba Y, Ishimoto T, Iwatsuki M, Hiyoshi Y, Miyamoto Y, Yoshida N, Wu R, Baba H. Progress in characterizing the linkage between Fusobacterium nucleatum and gastrointestinal cancer. J Gastroenterol 2019;54:33-41. [PMID: 30244399 DOI: 10.1007/s00535-018-1512-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
149 Wong SH, Yu J. Gut microbiota in colorectal cancer: mechanisms of action and clinical applications. Nat Rev Gastroenterol Hepatol. 2019;16:690-704. [PMID: 31554963 DOI: 10.1038/s41575-019-0209-8] [Cited by in Crossref: 164] [Cited by in F6Publishing: 150] [Article Influence: 54.7] [Reference Citation Analysis]
150 Liu L, Liang L, Yang C, Zhou Y, Chen Y. Extracellular vesicles of Fusobacterium nucleatum compromise intestinal barrier through targeting RIPK1-mediated cell death pathway. Gut Microbes 2021;13:1-20. [PMID: 33769187 DOI: 10.1080/19490976.2021.1902718] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
151 Cuellar-Gómez H, Ocharán-Hernández ME, Calzada-Mendoza CC, Comoto-Santacruz DA. Association of Fusobacterium nucleatum infection and colorectal cancer: A Mexican study. Rev Gastroenterol Mex 2021:S0375-0906(21)00035-5. [PMID: 34210555 DOI: 10.1016/j.rgmx.2020.12.002] [Reference Citation Analysis]
152 Bund T, Nikitina E, Chakraborty D, Ernst C, Gunst K, Boneva B, Tessmer C, Volk N, Brobeil A, Weber A, Heikenwalder M, Zur Hausen H, de Villiers EM. Analysis of chronic inflammatory lesions of the colon for BMMF Rep antigen expression and CD68 macrophage interactions. Proc Natl Acad Sci U S A 2021;118:e2025830118. [PMID: 33723077 DOI: 10.1073/pnas.2025830118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
153 Umaña A, Sanders BE, Yoo CC, Casasanta MA, Udayasuryan B, Verbridge SS, Slade DJ. Utilizing Whole Fusobacterium Genomes To Identify, Correct, and Characterize Potential Virulence Protein Families. J Bacteriol 2019;201:e00273-19. [PMID: 31501282 DOI: 10.1128/JB.00273-19] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 4.3] [Reference Citation Analysis]
154 Xu S, Yin W, Zhang Y, Lv Q, Yang Y, He J. Foes or Friends? Bacteria Enriched in the Tumor Microenvironment of Colorectal Cancer. Cancers (Basel) 2020;12:E372. [PMID: 32041122 DOI: 10.3390/cancers12020372] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
155 Klimesova K, Jiraskova Zakostelska Z, Tlaskalova-Hogenova H. Oral Bacterial and Fungal Microbiome Impacts Colorectal Carcinogenesis. Front Microbiol 2018;9:774. [PMID: 29731748 DOI: 10.3389/fmicb.2018.00774] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 7.3] [Reference Citation Analysis]
156 Li J, Li J, Lyu N, Ma Y, Liu F, Feng Y, Yao L, Hou Z, Song X, Zhao H, Li X, Wang Y, Xiao C, Zhu B. Composition of fecal microbiota in low-set rectal cancer patients treated with FOLFOX. Ther Adv Chronic Dis 2020;11:2040622320904293. [PMID: 32153743 DOI: 10.1177/2040622320904293] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
157 Qi W, Zhou X, Wang J, Zhang K, Zhou Y, Chen S, Nie S, Xie M. Cordyceps sinensis polysaccharide inhibits colon cancer cells growth by inducing apoptosis and autophagy flux blockage via mTOR signaling. Carbohydr Polym 2020;237:116113. [PMID: 32241434 DOI: 10.1016/j.carbpol.2020.116113] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
158 Liang S, Mao Y, Liao M, Xu Y, Chen Y, Huang X, Wei C, Wu C, Wang Q, Pan X, Tang W. Gut microbiome associated with APC gene mutation in patients with intestinal adenomatous polyps. Int J Biol Sci 2020;16:135-46. [PMID: 31892851 DOI: 10.7150/ijbs.37399] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
159 Zhang F, Cui B, He X, Nie Y, Wu K, Fan D; FMT-standardization Study Group. Microbiota transplantation: concept, methodology and strategy for its modernization. Protein Cell. 2018;9:462-473. [PMID: 29691757 DOI: 10.1007/s13238-018-0541-8] [Cited by in Crossref: 72] [Cited by in F6Publishing: 67] [Article Influence: 18.0] [Reference Citation Analysis]
160 Gerard L, Duvivier L, Gillet JP. Targeting tumor resistance mechanisms. Fac Rev 2021;10:6. [PMID: 33659924 DOI: 10.12703/r/10-6] [Reference Citation Analysis]
161 Jia W, Rajani C, Xu H, Zheng X. Gut microbiota alterations are distinct for primary colorectal cancer and hepatocellular carcinoma. Protein Cell 2021;12:374-93. [PMID: 32797354 DOI: 10.1007/s13238-020-00748-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
162 Song M, Chan AT, Sun J. Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer.Gastroenterology. 2020;158:322-340. [PMID: 31586566 DOI: 10.1053/j.gastro.2019.06.048] [Cited by in Crossref: 92] [Cited by in F6Publishing: 86] [Article Influence: 30.7] [Reference Citation Analysis]
163 Zhang R, Lin X, Liu H, Ma M, Chen J, Chen J, Gao D, Cui J, Chen R. Activated hepatic stellate cells promote progression of post-heat residual hepatocellular carcinoma from autophagic survival to proliferation. International Journal of Hyperthermia 2019;36:252-62. [DOI: 10.1080/02656736.2018.1558459] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
164 Zhang L, Li F, Qin WJ, Fu C, Zhang XL. Changes in intestinal microbiota affect metabolism of ginsenoside Re. Biomed Chromatogr 2018;32:e4284. [PMID: 29748959 DOI: 10.1002/bmc.4284] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
165 Mothersole RG, Billett CR, Saini G, Mothersole MK, Darbyshire AL, Wolthers KR. S224 Presents a Catalytic Trade-off in PLP-Dependent l-Lanthionine Synthase from Fusobacterium nucleatum. Biochemistry 2020;59:4250-61. [PMID: 33112129 DOI: 10.1021/acs.biochem.0c00683] [Reference Citation Analysis]
166 An Y, Zhang W, Liu T, Wang B, Cao H. The intratumoural microbiota in cancer: new insights from inside. Biochim Biophys Acta Rev Cancer 2021;1876:188626. [PMID: 34520804 DOI: 10.1016/j.bbcan.2021.188626] [Reference Citation Analysis]
167 Mohamed A, Menon H, Chulkina M, Yee NS, Pinchuk IV. Drug-Microbiota Interaction in Colon Cancer Therapy: Impact of Antibiotics. Biomedicines 2021;9:259. [PMID: 33807878 DOI: 10.3390/biomedicines9030259] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
168 Li B, Wei S, Yang L, Peng X, Ma Y, Wu B, Fan Q, Yang S, Li X, Jin H, Tang S, Huang M, Li H, Liu J. CISD2 Promotes Resistance to Sorafenib-Induced Ferroptosis by Regulating Autophagy in Hepatocellular Carcinoma. Front Oncol 2021;11:657723. [PMID: 34485112 DOI: 10.3389/fonc.2021.657723] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
169 Rho JH, Kim HJ, Joo JY, Lee JY, Lee JH, Park HR. Periodontal Pathogens Promote Foam Cell Formation by Blocking Lipid Efflux. J Dent Res 2021;:220345211008811. [PMID: 33899578 DOI: 10.1177/00220345211008811] [Reference Citation Analysis]
170 Liu J, Hsieh CL, Gelincik O, Devolder B, Sei S, Zhang S, Lipkin SM, Chang YF. Proteomic characterization of outer membrane vesicles from gut mucosa-derived fusobacterium nucleatum. J Proteomics. 2019;195:125-137. [PMID: 30634002 DOI: 10.1016/j.jprot.2018.12.029] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
171 Li Z, Shi C, Zheng J, Guo Y, Fan T, Zhao H, Jian D, Cheng X, Tang H, Ma J. Fusobacterium nucleatum predicts a high risk of metastasis for esophageal squamous cell carcinoma. BMC Microbiol 2021;21:301. [PMID: 34717543 DOI: 10.1186/s12866-021-02352-6] [Reference Citation Analysis]
172 Zhang YK, Zhang Q, Wang YL, Zhang WY, Hu HQ, Wu HY, Sheng XZ, Luo KJ, Zhang H, Wang M, Huang R, Wang GY. A Comparison Study of Age and Colorectal Cancer-Related Gut Bacteria. Front Cell Infect Microbiol 2021;11:606490. [PMID: 33996615 DOI: 10.3389/fcimb.2021.606490] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
173 Xu R, Wei Y, Yin X, Shi B, Li J. miR-20a suppresses chondrogenic differentiation of ATDC5 cells by regulating Atg7. Sci Rep 2019;9:9243. [PMID: 31239522 DOI: 10.1038/s41598-019-45502-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
174 Yang J, Yang Y, Ishii M, Nagata M, Aw W, Obana N, Tomita M, Nomura N, Fukuda S. Does the Gut Microbiota Modulate Host Physiology through Polymicrobial Biofilms? Microbes Environ 2020;35. [PMID: 32624527 DOI: 10.1264/jsme2.ME20037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
175 Hertel J, Heinken A, Martinelli F, Thiele I. Integration of constraint-based modeling with fecal metabolomics reveals large deleterious effects of Fusobacterium spp. on community butyrate production. Gut Microbes 2021;13:1-23. [PMID: 34057024 DOI: 10.1080/19490976.2021.1915673] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
176 Guo J, Liao M, Wang J. TLR4 signaling in the development of colitis-associated cancer and its possible interplay with microRNA-155. Cell Commun Signal 2021;19:90. [PMID: 34479599 DOI: 10.1186/s12964-021-00771-6] [Reference Citation Analysis]
177 Kang W, Sun T, Tang D, Zhou J, Feng Q. Time-Course Transcriptome Analysis of Gingiva-Derived Mesenchymal Stem Cells Reveals That Fusobacterium nucleatum Triggers Oncogene Expression in the Process of Cell Differentiation. Front Cell Dev Biol 2019;7:359. [PMID: 31993418 DOI: 10.3389/fcell.2019.00359] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
178 Martin-Gallausiaux C, Malabirade A, Habier J, Wilmes P. Fusobacterium nucleatum Extracellular Vesicles Modulate Gut Epithelial Cell Innate Immunity via FomA and TLR2. Front Immunol 2020;11:583644. [PMID: 33408714 DOI: 10.3389/fimmu.2020.583644] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
179 Silva M, Brunner V, Tschurtschenthaler M. Microbiota and Colorectal Cancer: From Gut to Bedside. Front Pharmacol 2021;12:760280. [PMID: 34658896 DOI: 10.3389/fphar.2021.760280] [Reference Citation Analysis]
180 Yu ZK, Xie RL, You R, Liu YP, Chen XY, Chen MY, Huang PY. The role of the bacterial microbiome in the treatment of cancer. BMC Cancer 2021;21:934. [PMID: 34412621 DOI: 10.1186/s12885-021-08664-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
181 Liu H, Li L, Zou J, Zhou T, Wang B, Sun H, Yu S. Coix seed oil ameliorates cancer cachexia by counteracting muscle loss and fat lipolysis. BMC Complement Altern Med 2019;19:267. [PMID: 31615487 DOI: 10.1186/s12906-019-2684-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
182 Wang Y, Du J, Wu X, Abdelrehem A, Ren Y, Liu C, Zhou X, Wang S. Crosstalk between autophagy and microbiota in cancer progression. Mol Cancer 2021;20:163. [PMID: 34895252 DOI: 10.1186/s12943-021-01461-0] [Reference Citation Analysis]
183 Xu G, Feng D, Yao Y, Li P, Sun H, Yang H, Li C, Jiang R, Sun B, Chen Y. Listeria-based hepatocellular carcinoma vaccine facilitates anti-PD-1 therapy by regulating macrophage polarization. Oncogene 2020;39:1429-44. [PMID: 31659256 DOI: 10.1038/s41388-019-1072-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
184 Yang J, Wang C, Shi S, Dong C. Nanotechnologies for enhancing cancer immunotherapy. Nano Res 2020;13:2595-616. [DOI: 10.1007/s12274-020-2904-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
185 Pasquereau-Kotula E, Martins M, Aymeric L, Dramsi S. Significance of Streptococcus gallolyticus subsp. gallolyticus Association With Colorectal Cancer. Front Microbiol 2018;9:614. [PMID: 29666615 DOI: 10.3389/fmicb.2018.00614] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 10.0] [Reference Citation Analysis]
186 Gao NL, Zhang C, Zhang Z, Hu S, Lercher MJ, Zhao XM, Bork P, Liu Z, Chen WH. MVP: a microbe-phage interaction database. Nucleic Acids Res 2018;46:D700-7. [PMID: 29177508 DOI: 10.1093/nar/gkx1124] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 10.3] [Reference Citation Analysis]
187 Kim YJ, Kim BK, Park SJ, Kim JH. Impact of Fusobacterium nucleatum in the gastrointestinal tract on natural killer cells. World J Gastroenterol 2021; 27(29): 4879-4889 [PMID: 34447232 DOI: 10.3748/wjg.v27.i29.4879] [Reference Citation Analysis]
188 Park CH, Eun CS, Han DS. Intestinal microbiota, chronic inflammation, and colorectal cancer. Intest Res. 2018;16:338-345. [PMID: 30090032 DOI: 10.5217/ir.2018.16.3.338] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 9.8] [Reference Citation Analysis]
189 Todd SM, Settlage RE, Lahmers KK, Slade DJ. Fusobacterium Genomics Using MinION and Illumina Sequencing Enables Genome Completion and Correction. mSphere 2018;3:e00269-18. [PMID: 29976645 DOI: 10.1128/mSphere.00269-18] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
190 Rastogi YR, Saini AK, Thakur VK, Saini RV. New Insights into Molecular Links Between Microbiota and Gastrointestinal Cancers: A Literature Review. Int J Mol Sci 2020;21:E3212. [PMID: 32370077 DOI: 10.3390/ijms21093212] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
191 Elsalem L, Jum'ah AA, Alfaqih MA, Aloudat O. The Bacterial Microbiota of Gastrointestinal Cancers: Role in Cancer Pathogenesis and Therapeutic Perspectives. Clin Exp Gastroenterol 2020;13:151-85. [PMID: 32440192 DOI: 10.2147/CEG.S243337] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
192 Plat VD, van Rossen TM, Daams F, de Boer NK, de Meij TGJ, Budding AE, Vandenbroucke-Grauls CMJE, van der Peet DL. Esophageal microbiota composition and outcome of esophageal cancer treatment: a systematic review. Dis Esophagus 2021:doab076. [PMID: 34761269 DOI: 10.1093/dote/doab076] [Reference Citation Analysis]
193 Wu H, Ma Y, Peng X, Qiu W, Kong L, Ren B, Li M, Cheng G, Zhou X, Cheng L. Antibiotic-induced dysbiosis of the rat oral and gut microbiota and resistance to Salmonella. Arch Oral Biol 2020;114:104730. [PMID: 32371145 DOI: 10.1016/j.archoralbio.2020.104730] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
194 López-Gómez M, García de Santiago B, Delgado-López PD, Malmierca E, González-Olmedo J, Gómez-Raposo C, Sandoval C, Ruiz-Seco P, Escribano N, Gómez-Cerezo JF, Casado E. Gastrointestinal tumors and infectious agents: A wide field to explore. World J Meta-Anal 2021; 9(6): 505-521 [DOI: 10.13105/wjma.v9.i6.505] [Reference Citation Analysis]
195 Bronzato JD, Bomfim RA, Edwards DH, Crouch D, Hector MP, Gomes BPFA. Detection of Fusobacterium in oral and head and neck cancer samples: A systematic review and meta-analysis. Arch Oral Biol 2020;112:104669. [PMID: 32028171 DOI: 10.1016/j.archoralbio.2020.104669] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
196 Zhu R, Lang T, Yan W, Zhu X, Huang X, Yin Q, Li Y. Gut Microbiota: Influence on Carcinogenesis and Modulation Strategies by Drug Delivery Systems to Improve Cancer Therapy. Adv Sci (Weinh) 2021;8:2003542. [PMID: 34026439 DOI: 10.1002/advs.202003542] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
197 Sethi V, Vitiello GA, Saxena D, Miller G, Dudeja V. The Role of the Microbiome in Immunologic Development and its Implication For Pancreatic Cancer Immunotherapy. Gastroenterology 2019;156:2097-2115.e2. [DOI: 10.1053/j.gastro.2018.12.045] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 12.3] [Reference Citation Analysis]
198 Lu S, Ding X, Wang Y, Hu X, Sun T, Wei M, Wang X, Wu H. The Relationship Between the Network of Non-coding RNAs-Molecular Targets and N6-Methyladenosine Modification in Colorectal Cancer. Front Cell Dev Biol 2021;9:772542. [PMID: 34938735 DOI: 10.3389/fcell.2021.772542] [Reference Citation Analysis]
199 Guz M, Jeleniewicz W, Malm A, Korona-Glowniak I. A Crosstalk between Diet, Microbiome and microRNA in Epigenetic Regulation of Colorectal Cancer. Nutrients 2021;13:2428. [PMID: 34371938 DOI: 10.3390/nu13072428] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
200 Lee YP, Chiu CC, Lin TJ, Hung SW, Huang WC, Chiu CF, Huang YT, Chen YH, Chen TH, Chuang HL. The germ-free mice monocolonization with Bacteroides fragilis improves azoxymethane/dextran sulfate sodium induced colitis-associated colorectal cancer. Immunopharmacol Immunotoxicol 2019;41:207-13. [PMID: 30706742 DOI: 10.1080/08923973.2019.1569047] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
201 Dong J, Tai JW, Lu LF. miRNA-Microbiota Interaction in Gut Homeostasis and Colorectal Cancer. Trends Cancer 2019;5:666-9. [PMID: 31735285 DOI: 10.1016/j.trecan.2019.08.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
202 Lin R, Han C, Ding Z, Shi H, He R, Liu J, Qian W, Zhang Q, Fu X, Deng X, Zhou S, Hou X. Knock down of BMSC-derived Wnt3a or its antagonist analogs attenuate colorectal carcinogenesis induced by chronic Fusobacterium nucleatum infection. Cancer Lett 2020;495:165-79. [PMID: 32920199 DOI: 10.1016/j.canlet.2020.08.032] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
203 Du GH, Wang YF, Chen JJ, Deng YW, Han XZ, Tang GY. Potential association between Fusobacterium nucleatum enrichment on oral mucosal surface and oral lichen planus. Oral Dis 2020;26:122-30. [PMID: 31710746 DOI: 10.1111/odi.13232] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
204 Zhang J, Lu Y, Wang Y, Ren X, Han J. The impact of the intestinal microbiome on bone health. Intractable Rare Dis Res 2018;7:148-55. [PMID: 30181933 DOI: 10.5582/irdr.2018.01055] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
205 Mo Y, Wang Y, Zhang L, Yang L, Zhou M, Li X, Li Y, Li G, Zeng Z, Xiong W, Xiong F, Guo C. The role of Wnt signaling pathway in tumor metabolic reprogramming. J Cancer 2019;10:3789-97. [PMID: 31333796 DOI: 10.7150/jca.31166] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 13.3] [Reference Citation Analysis]
206 Deng Y, Liu SY, Chua SL, Khoo BL. The effects of biofilms on tumor progression in a 3D cancer-biofilm microfluidic model. Biosensors and Bioelectronics 2021;180:113113. [DOI: 10.1016/j.bios.2021.113113] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
207 Chen X, Liu F, Chen B, Wu H, Li K, Xie Y, Kuang W, Li Z. Novel lysosome-targeted anticancer fluorescent agents used in zebrafish and nude mouse tumour imaging. Front Chem Sci Eng 2022;16:112-20. [DOI: 10.1007/s11705-021-2075-5] [Reference Citation Analysis]
208 Ying HQ, Sun F, Liao YC, Cai D, Yang Y, Cheng XX. The value of circulating fibrinogen-to-pre-albumin ratio in predicting survival and benefit from chemotherapy in colorectal cancer. Ther Adv Med Oncol 2021;13:17588359211022886. [PMID: 34262615 DOI: 10.1177/17588359211022886] [Reference Citation Analysis]
209 Sun D, Chen Y, Fang JY. Influence of the microbiota on epigenetics in colorectal cancer. Natl Sci Rev 2019;6:1138-48. [PMID: 34691992 DOI: 10.1093/nsr/nwy160] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
210 Yan C, Wang C, Hou T, Guan P, Qiao Y, Guo L, Teng Y, Hu X, Wu H. Lasting Tracking and Rapid Discrimination of Live Gram-Positive Bacteria by Peptidoglycan-Targeting Carbon Quantum Dots. ACS Appl Mater Interfaces 2021;13:1277-87. [PMID: 33393300 DOI: 10.1021/acsami.0c19651] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
211 Wang L, Peng F, Peng C, Du JR. Gut Microbiota in Tumor Microenvironment: A Critical Regulator in Cancer Initiation and Development as Potential Targets for Chinese Medicine. Am J Chin Med 2021;49:609-26. [PMID: 33683187 DOI: 10.1142/S0192415X21500270] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
212 Wong SH, Kwong TNY, Wu CY, Yu J. Clinical applications of gut microbiota in cancer biology. Semin Cancer Biol 2019;55:28-36. [PMID: 29782923 DOI: 10.1016/j.semcancer.2018.05.003] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 10.0] [Reference Citation Analysis]
213 Lu H, Gao NL, Tong F, Wang J, Li H, Zhang R, Ma H, Yang N, Zhang Y, Wang Y, Liang Z, Zeng H, Chen WH, Dong X. Alterations of the Human Lung and Gut Microbiomes in Non-Small Cell Lung Carcinomas and Distant Metastasis. Microbiol Spectr 2021;:e0080221. [PMID: 34787462 DOI: 10.1128/Spectrum.00802-21] [Reference Citation Analysis]
214 Yamamoto S, Kinugasa H, Hirai M, Terasawa H, Yasutomi E, Oka S, Ohmori M, Yamasaki Y, Inokuchi T, Harada K, Hiraoka S, Nouso K, Tanaka T, Teraishi F, Fujiwara T, Okada H. Heterogeneous distribution of Fusobacterium nucleatum in the progression of colorectal cancer. J Gastroenterol Hepatol 2021;36:1869-76. [PMID: 33242360 DOI: 10.1111/jgh.15361] [Reference Citation Analysis]
215 D'Amico F, Perrone AM, Rampelli S, Coluccelli S, Barone M, Ravegnini G, Fabbrini M, Brigidi P, De Iaco P, Turroni S. Gut Microbiota Dynamics during Chemotherapy in Epithelial Ovarian Cancer Patients Are Related to Therapeutic Outcome. Cancers (Basel) 2021;13:3999. [PMID: 34439153 DOI: 10.3390/cancers13163999] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
216 Kunzmann AT, Proença MA, Jordao HW, Jiraskova K, Schneiderova M, Levy M, Liska V, Buchler T, Vodickova L, Vymetalkova V, Silva AE, Vodicka P, Hughes DJ. Fusobacterium nucleatum tumor DNA levels are associated with survival in colorectal cancer patients. Eur J Clin Microbiol Infect Dis 2019;38:1891-9. [PMID: 31367996 DOI: 10.1007/s10096-019-03649-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
217 Chau J, Zhang J. Tying Small Changes to Large Outcomes: The Cautious Promise in Incorporating the Microbiome into Immunotherapy. Int J Mol Sci 2021;22:7900. [PMID: 34360663 DOI: 10.3390/ijms22157900] [Reference Citation Analysis]
218 Zhou C, Yi C, Yi Y, Qin W, Yan Y, Dong X, Zhang X, Huang Y, Zhang R, Wei J, Ali DW, Michalak M, Chen XZ, Tang J. LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619-5p/Pygo2 and miR-619-5p/ATG14 axes. Mol Cancer 2020;19:118. [PMID: 32727463 DOI: 10.1186/s12943-020-01237-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 15.0] [Reference Citation Analysis]
219 Gaiani F, Marchesi F, Negri F, Greco L, Malesci A, de'Angelis GL, Laghi L. Heterogeneity of Colorectal Cancer Progression: Molecular Gas and Brakes. Int J Mol Sci 2021;22:5246. [PMID: 34063506 DOI: 10.3390/ijms22105246] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
220 Jiang Y, Ji X, Liu K, Shi Y, Wang C, Li Y, Zhang T, He Y, Xiang M, Zhao R. Exosomal miR-200c-3p negatively regulates the migraion and invasion of lipopolysaccharide (LPS)-stimulated colorectal cancer (CRC). BMC Mol Cell Biol 2020;21:48. [PMID: 32600257 DOI: 10.1186/s12860-020-00291-0] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
221 Zhang H, Hui D, Li Y, Xiong G, Fu X. Canmei Formula Reduces Colitis-Associated Colorectal Carcinogenesis in Mice by Modulating the Composition of Gut Microbiota. Front Oncol 2019;9:1149. [PMID: 31803606 DOI: 10.3389/fonc.2019.01149] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
222 Kouzu K, Tsujimoto H, Kishi Y, Ueno H, Shinomiya N. Role of Microbial Infection-Induced Inflammation in the Development of Gastrointestinal Cancers. Medicines (Basel) 2021;8:45. [PMID: 34436224 DOI: 10.3390/medicines8080045] [Reference Citation Analysis]
223 Cheng L, Kaźmierczak D, Norenhag J, Hamsten M, Fransson E, Schuppe-Koistinen I, Olovsson M, Engstrand L, Hydbring P, Du J. A MicroRNA Gene Panel Predicts the Vaginal Microbiota Composition. mSystems 2021;6:e00175-21. [PMID: 33947805 DOI: 10.1128/mSystems.00175-21] [Reference Citation Analysis]
224 Zhou H, Yuan Y, Wang H, Xiang W, Li S, Zheng H, Wen Y, Ming Y, Chen L, Zhou J. Gut Microbiota: A Potential Target for Cancer Interventions. Cancer Manag Res 2021;13:8281-96. [PMID: 34764691 DOI: 10.2147/CMAR.S328249] [Reference Citation Analysis]
225 Kovaleva OV, Romashin D, Zborovskaya IB, Davydov MM, Shogenov MS, Gratchev A. Human Lung Microbiome on the Way to Cancer. J Immunol Res 2019;2019:1394191. [PMID: 31485458 DOI: 10.1155/2019/1394191] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
226 Cuellar-Gómez H, Ocharán-Hernández ME, Calzada-Mendoza CC, Comoto-Santacruz DA. Association of Fusobacterium nucleatum infection and colorectal cancer: A Mexican study. Rev Gastroenterol Mex (Engl Ed) 2021:S2255-534X(21)00074-8. [PMID: 34312118 DOI: 10.1016/j.rgmxen.2021.07.001] [Reference Citation Analysis]
227 Wang S, Liu Y, Li J, Zhao L, Yan W, Lin B, Guo X, Wei Y. Fusobacterium nucleatum Acts as a Pro-carcinogenic Bacterium in Colorectal Cancer: From Association to Causality. Front Cell Dev Biol 2021;9:710165. [PMID: 34490259 DOI: 10.3389/fcell.2021.710165] [Reference Citation Analysis]
228 Zhou X, Zhang S, Liu D, Qian H, Zhang D, Liu Q. The differences between fecal microbiota and intestinal fluid microbiota in colon polyps: An observational study. Medicine (Baltimore) 2021;100:e28028. [PMID: 34967350 DOI: 10.1097/MD.0000000000028028] [Reference Citation Analysis]
229 Pan L, Du M, Liu H, Cheng B, Zhu M, Jia B, Wang Y, He W, Li X, Liu C, Gu J, Li M, Zhang Y, Yao L, Zhang Y, Hao Q. LncRNA FTX promotes the malignant progression of colorectal cancer by regulating the miR-214-5p-JAG1 axis. Ann Transl Med 2021;9:1369. [PMID: 34733921 DOI: 10.21037/atm-21-2755] [Reference Citation Analysis]
230 Zhang X, Li Q, Du A, Li Y, Shi Q, Chen Y, Zhao Y, Wang B, Pan F. Adipocytic Glutamine Synthetase Upregulation via Altered Histone Methylation Promotes 5FU Chemoresistance in Peritoneal Carcinomatosis of Colorectal Cancer. Front Oncol 2021;11:748730. [PMID: 34712612 DOI: 10.3389/fonc.2021.748730] [Reference Citation Analysis]
231 Purcell RV, Kaakoush NO, Mitchell HM, Pearson JF, Keenan JI. Gastrointestinal Pathobionts in Pediatric Crohn's Disease Patients. Int J Microbiol 2018;2018:9203908. [PMID: 30123276 DOI: 10.1155/2018/9203908] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
232 Tarashi S, Siadat SD, Ahmadi Badi S, Zali M, Biassoni R, Ponzoni M, Moshiri A. Gut Bacteria and their Metabolites: Which One Is the Defendant for Colorectal Cancer? Microorganisms 2019;7:E561. [PMID: 31766208 DOI: 10.3390/microorganisms7110561] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 3.7] [Reference Citation Analysis]
233 Chu Y, Wang Y, Li K, Liu M, Zhang Y, Li Y, Hu X, Liu C, Zhou H, Zuo J, Peng W. Human omental adipose-derived mesenchymal stem cells enhance autophagy in ovarian carcinoma cells through the STAT3 signalling pathway. Cell Signal 2020;69:109549. [PMID: 31987780 DOI: 10.1016/j.cellsig.2020.109549] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
234 Xie YH, Chen YX, Fang JY. Comprehensive review of targeted therapy for colorectal cancer. Signal Transduct Target Ther 2020;5:22. [PMID: 32296018 DOI: 10.1038/s41392-020-0116-z] [Cited by in Crossref: 130] [Cited by in F6Publishing: 140] [Article Influence: 65.0] [Reference Citation Analysis]
235 Koliarakis I, Athanasakis E, Sgantzos M, Mariolis-Sapsakos T, Xynos E, Chrysos E, Souglakos J, Tsiaoussis J. Intestinal Microbiota in Colorectal Cancer Surgery. Cancers (Basel) 2020;12:E3011. [PMID: 33081401 DOI: 10.3390/cancers12103011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
236 Chen Y, Chen Y, Zhang J, Cao P, Su W, Deng Y, Zhan N, Fu X, Huang Y, Dong W. Fusobacterium nucleatum Promotes Metastasis in Colorectal Cancer by Activating Autophagy Signaling via the Upregulation of CARD3 Expression. Theranostics 2020;10:323-39. [PMID: 31903123 DOI: 10.7150/thno.38870] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
237 Dong J, Gao HL, Wang WQ, Yu XJ, Liu L. Bidirectional and dynamic interaction between the microbiota and therapeutic resistance in pancreatic cancer. Biochim Biophys Acta Rev Cancer 2021;1875:188484. [PMID: 33246025 DOI: 10.1016/j.bbcan.2020.188484] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
238 Gao S, Liu Y, Duan X, Liu K, Mohammed M, Gu Z, Ren J, Yakoumatos L, Yuan X, Lu L, Liang S, Li J, Scott DA, Lamont RJ, Zhou F, Wang H. Porphyromonas gingivalis infection exacerbates oesophageal cancer and promotes resistance to neoadjuvant chemotherapy. Br J Cancer 2021;125:433-44. [PMID: 33981017 DOI: 10.1038/s41416-021-01419-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
239 Ogino S, Nowak JA, Hamada T, Milner DA Jr, Nishihara R. Insights into Pathogenic Interactions Among Environment, Host, and Tumor at the Crossroads of Molecular Pathology and Epidemiology. Annu Rev Pathol. 2019;14:83-103. [PMID: 30125150 DOI: 10.1146/annurev-pathmechdis-012418-012818] [Cited by in Crossref: 87] [Cited by in F6Publishing: 87] [Article Influence: 21.8] [Reference Citation Analysis]
240 Singh RP, Bashir H, Kumar R. Emerging role of microbiota in immunomodulation and cancer immunotherapy. Semin Cancer Biol 2021;70:37-52. [PMID: 32580024 DOI: 10.1016/j.semcancer.2020.06.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
241 Andrews MC, Reuben A, Gopalakrishnan V, Wargo JA. Concepts Collide: Genomic, Immune, and Microbial Influences on the Tumor Microenvironment and Response to Cancer Therapy. Front Immunol 2018;9:946. [PMID: 29780391 DOI: 10.3389/fimmu.2018.00946] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
242 Huangfu SC, Zhang WB, Zhang HR, Li Y, Zhang YR, Nie JL, Chu XD, Chen CS, Jiang HP, Pan JH. Clinicopathological and prognostic significance of Fusobacterium nucleatum infection in colorectal cancer: a meta-analysis. J Cancer 2021;12:1583-91. [PMID: 33613745 DOI: 10.7150/jca.50111] [Reference Citation Analysis]
243 Lynch SV, Ng SC, Shanahan F, Tilg H. Translating the gut microbiome: ready for the clinic? Nat Rev Gastroenterol Hepatol 2019;16:656-61. [PMID: 31562390 DOI: 10.1038/s41575-019-0204-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
244 Song J, Zhou Y, Gong Y, Liu H, Tang L. Rottlerin promotes autophagy and apoptosis in gastric cancer cell lines. Mol Med Rep 2018;18:2905-13. [PMID: 30015872 DOI: 10.3892/mmr.2018.9293] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
245 Gopalakrishnan V, Weiner B, Ford C, Sellman B, Hammond S, Freeman D, Dennis P, Soria J, Wortman J, Henn M. Intervention strategies for microbial therapeutics in cancer immunotherapy. Immuno-Oncology Technology 2020;6:9-17. [DOI: 10.1016/j.iotech.2020.05.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
246 Sánchez-Alcoholado L, Ordóñez R, Otero A, Plaza-Andrade I, Laborda-Illanes A, Medina JA, Ramos-Molina B, Gómez-Millán J, Queipo-Ortuño MI. Gut Microbiota-Mediated Inflammation and Gut Permeability in Patients with Obesity and Colorectal Cancer. Int J Mol Sci 2020;21:E6782. [PMID: 32947866 DOI: 10.3390/ijms21186782] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
247 Issac J, Raveendran PS, Das AV. RFX1: a promising therapeutic arsenal against cancer. Cancer Cell Int 2021;21:253. [PMID: 33964962 DOI: 10.1186/s12935-021-01952-6] [Reference Citation Analysis]
248 Yu D, Yang J, Jin M, Zhou B, Shi L, Zhao L, Zhang J, Lin Z, Ren J, Liu L, Zhang T, Liu H. Fecal Streptococcus Alteration Is Associated with Gastric Cancer Occurrence and Liver Metastasis. mBio 2021;12:e0299421. [PMID: 34872346 DOI: 10.1128/mBio.02994-21] [Reference Citation Analysis]
249 Hekmatshoar Y, Rahbar Saadat Y, Hosseiniyan Khatibi SM, Ozkan T, Zununi Vahed F, Nariman-Saleh-Fam Z, Pourghassem Gargari B, Sunguroglu A, Zununi Vahed S. The impact of tumor and gut microbiotas on cancer therapy: Beneficial or detrimental? Life Sci 2019;233:116680. [PMID: 31344431 DOI: 10.1016/j.lfs.2019.116680] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
250 Zhang S, Li C, Liu J, Geng F, Shi X, Li Q, Lu Z, Pan Y. Fusobacterium nucleatum promotes epithelial-mesenchymal transiton through regulation of the lncRNA MIR4435-2HG/miR-296-5p/Akt2/SNAI1 signaling pathway. FEBS J 2020;287:4032-47. [PMID: 31997506 DOI: 10.1111/febs.15233] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
251 Choy AT, Carnevale I, Coppola S, Meijer LL, Kazemier G, Zaura E, Deng D, Giovannetti E. The microbiome of pancreatic cancer: from molecular diagnostics to new therapeutic approaches to overcome chemoresistance caused by metabolic inactivation of gemcitabine. Expert Review of Molecular Diagnostics 2018;18:1005-9. [DOI: 10.1080/14737159.2018.1544495] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
252 Koliarakis I, Messaritakis I, Nikolouzakis TK, Hamilos G, Souglakos J, Tsiaoussis J. Oral Bacteria and Intestinal Dysbiosis in Colorectal Cancer. Int J Mol Sci 2019;20:E4146. [PMID: 31450675 DOI: 10.3390/ijms20174146] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 13.0] [Reference Citation Analysis]
253 Ma L, Liu H, Wang X, Jiang C, Yao S, Guo Y, Wang H, Cao Z. CXXC5 orchestrates Stat3/Erk/Akt signaling networks to modulate P. gingivalis-elicited autophagy in cementoblasts. Biochim Biophys Acta Mol Cell Res 2021;1868:118923. [PMID: 33285176 DOI: 10.1016/j.bbamcr.2020.118923] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
254 Geller LT, Barzily-Rokni M, Danino T, Jonas OH, Shental N, Nejman D, Gavert N, Zwang Y, Cooper ZA, Shee K, Thaiss CA, Reuben A, Livny J, Avraham R, Frederick DT, Ligorio M, Chatman K, Johnston SE, Mosher CM, Brandis A, Fuks G, Gurbatri C, Gopalakrishnan V, Kim M, Hurd MW, Katz M, Fleming J, Maitra A, Smith DA, Skalak M, Bu J, Michaud M, Trauger SA, Barshack I, Golan T, Sandbank J, Flaherty KT, Mandinova A, Garrett WS, Thayer SP, Ferrone CR, Huttenhower C, Bhatia SN, Gevers D, Wargo JA, Golub TR, Straussman R. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science. 2017;357:1156-1160. [PMID: 28912244 DOI: 10.1126/science.aah5043] [Cited by in Crossref: 410] [Cited by in F6Publishing: 383] [Article Influence: 102.5] [Reference Citation Analysis]
255 Perillo F, Amoroso C, Strati F, Giuffrè MR, Díaz-Basabe A, Lattanzi G, Facciotti F. Gut Microbiota Manipulation as a Tool for Colorectal Cancer Management: Recent Advances in Its Use for Therapeutic Purposes. Int J Mol Sci 2020;21:E5389. [PMID: 32751239 DOI: 10.3390/ijms21155389] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
256 Tan J, Wang HL, Yang J, Liu QQ, Li CM, Wang YQ, Fu LN, Gao QY, Chen YX, Fang JY. JMJD2B-induced amino acid alterations enhance the survival of colorectal cancer cells under glucose-deprivation via autophagy. Theranostics 2020;10:5763-77. [PMID: 32483417 DOI: 10.7150/thno.38087] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
257 Cong J, Zhang X. How human microbiome talks to health and disease. Eur J Clin Microbiol Infect Dis 2018;37:1595-601. [PMID: 29682676 DOI: 10.1007/s10096-018-3263-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
258 Hong J, Guo F, Lu SY, Shen C, Ma D, Zhang X, Xie Y, Yan T, Yu T, Sun T, Qian Y, Zhong M, Chen J, Peng Y, Wang C, Zhou X, Liu J, Liu Q, Ma X, Chen YX, Chen H, Fang JY. F. nucleatum targets lncRNA ENO1-IT1 to promote glycolysis and oncogenesis in colorectal cancer. Gut 2020:gutjnl-2020-322780. [PMID: 33318144 DOI: 10.1136/gutjnl-2020-322780] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
259 Zheng DW, Dong X, Pan P, Chen KW, Fan JX, Cheng SX, Zhang XZ. Phage-guided modulation of the gut microbiota of mouse models of colorectal cancer augments their responses to chemotherapy. Nat Biomed Eng. 2019;3:717-728. [PMID: 31332342 DOI: 10.1038/s41551-019-0423-2] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 20.3] [Reference Citation Analysis]
260 Yang X, Zou J, Cai H, Huang X, Yang X, Guo D, Cao Y. Ginsenoside Rg3 inhibits colorectal tumor growth via down-regulation of C/EBPβ/NF-κB signaling. Biomedicine & Pharmacotherapy 2017;96:1240-5. [DOI: 10.1016/j.biopha.2017.11.092] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
261 Huang X, Li M, Hou S, Tian B. Role of the microbiome in systemic therapy for pancreatic ductal adenocarcinoma (Review). Int J Oncol 2021;59:101. [PMID: 34738624 DOI: 10.3892/ijo.2021.5281] [Reference Citation Analysis]
262 Wei LQ, Cheong IH, Yang GH, Li XG, Kozlakidis Z, Ding L, Liu NN, Wang H. The Application of High-Throughput Technologies for the Study of Microbiome and Cancer. Front Genet 2021;12:699793. [PMID: 34394190 DOI: 10.3389/fgene.2021.699793] [Reference Citation Analysis]
263 Tang R, Chen J, Tang M, Liao Z, Zhou L, Jiang J, Hu Y, Liao Q, Xiong W, Tang Y, Nie S. LncRNA SLCO4A1-AS1 predicts poor prognosis and promotes proliferation and metastasis via the EGFR/MAPK pathway in colorectal cancer. Int J Biol Sci 2019;15:2885-96. [PMID: 31853225 DOI: 10.7150/ijbs.38041] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
264 Chen Y, Chen Y, Cao P, Su W, Zhan N, Dong W. Fusobacterium nucleatum facilitates ulcerative colitis through activating IL-17F signaling to NF-κB via the upregulation of CARD3 expression.J Pathol. 2020;250:170-182. [PMID: 31610014 DOI: 10.1002/path.5358] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
265 Vinogradov E, St Michael F, Cox AD. Structure of the LPS O-chain from Fusobacterium nucleatum strain ATCC 23726 containing a novel 5,7-diamino-3,5,7,9-tetradeoxy-l-gluco-non-2-ulosonic acid presumably having the d-glycero-l-gluco configuration. Carbohydr Res 2018;468:69-72. [PMID: 30153554 DOI: 10.1016/j.carres.2018.08.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
266 Gong TT, He XH, Gao S, Wu QJ. Application of machine learning in prediction of Chemotherapy resistant of Ovarian Cancer based on Gut Microbiota. J Cancer 2021;12:2877-85. [PMID: 33854588 DOI: 10.7150/jca.46621] [Reference Citation Analysis]
267 Ogino S, Nowak JA, Hamada T, Phipps AI, Peters U, Milner DA, Giovannucci EL, Nishihara R, Giannakis M, Garrett WS, Song M. Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine. Gut. 2018;67:1168-1180. [PMID: 29437869 DOI: 10.1136/gutjnl-2017-315537] [Cited by in Crossref: 93] [Cited by in F6Publishing: 91] [Article Influence: 23.3] [Reference Citation Analysis]
268 Yan X, Liu L, Li H, Qin H, Sun Z. Clinical significance of Fusobacterium nucleatum, epithelial-mesenchymal transition, and cancer stem cell markers in stage III/IV colorectal cancer patients. Onco Targets Ther 2017;10:5031-46. [PMID: 29081665 DOI: 10.2147/OTT.S145949] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 7.6] [Reference Citation Analysis]
269 Bai J, Chen H, Bai X. Relationship between microsatellite status and immune microenvironment of colorectal cancer and its application to diagnosis and treatment. J Clin Lab Anal 2021;35:e23810. [PMID: 33938589 DOI: 10.1002/jcla.23810] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
270 Chen S, Su T, Zhang Y, Lee A, He J, Ge Q, Wang L, Si J, Zhuo W, Wang L. Fusobacterium nucleatum promotes colorectal cancer metastasis by modulating KRT7-AS/KRT7. Gut Microbes 2020;11:511-25. [PMID: 31910722 DOI: 10.1080/19490976.2019.1695494] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
271 Ma WJ, Jin YW, Wu ZR, Yang Q, Wang JK, Liu F, Shi YJ, Li QS, Cheng NS. Meta-analysis of randomized clinical trials of adjuvant chemotherapy for resected biliary tract cancers. HPB (Oxford) 2020;22:939-49. [PMID: 32349925 DOI: 10.1016/j.hpb.2020.02.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
272 Li D, He R, Hou G, Ming W, Fan T, Chen L, Zhang L, Jiang W, Wang W, Lu Z, Feng H, Geng Q. Characterization of the Esophageal Microbiota and Prediction of the Metabolic Pathways Involved in Esophageal Cancer. Front Cell Infect Microbiol 2020;10:268. [PMID: 32676460 DOI: 10.3389/fcimb.2020.00268] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
273 Ding Z, Wang W, Zhang K, Ming F, Yangdai T, Xu T, Shi H, Bao Y, Yao H, Peng H, Han C, Jiang W, Liu J, Hou X, Lin R. Novel scheme for non-invasive gut bioinformation acquisition with a magnetically controlled sampling capsule endoscope. Gut 2021:gutjnl-2020-322465. [PMID: 33452177 DOI: 10.1136/gutjnl-2020-322465] [Reference Citation Analysis]
274 Lucas C, Salesse L, Hoang MHT, Bonnet M, Sauvanet P, Larabi A, Godfraind C, Gagnière J, Pezet D, Rosenstiel P, Barnich N, Bonnet R, Dalmasso G, Nguyen HTT. Autophagy of Intestinal Epithelial Cells Inhibits Colorectal Carcinogenesis Induced by Colibactin-Producing Escherichia coli in ApcMin/+ Mice. Gastroenterology 2020;158:1373-88. [PMID: 31917256 DOI: 10.1053/j.gastro.2019.12.026] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
275 Wang X, Lan Z, He J, Lai Q, Yao X, Li Q, Liu Y, Lai H, Gu C, Yan Q, Fang Y, Zhang Y, Li A, Liu S. LncRNA SNHG6 promotes chemoresistance through ULK1-induced autophagy by sponging miR-26a-5p in colorectal cancer cells. Cancer Cell Int 2019;19:234. [PMID: 31516391 DOI: 10.1186/s12935-019-0951-6] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 13.7] [Reference Citation Analysis]
276 Chen J, Li T, Liang J, Huang Q, Huang JD, Ke Y, Sun H. Current status of intratumour microbiome in cancer and engineered exogenous microbiota as a promising therapeutic strategy. Biomed Pharmacother 2022;145:112443. [PMID: 34847476 DOI: 10.1016/j.biopha.2021.112443] [Reference Citation Analysis]
277 Chen S, Wang Y, Wang B, Zhang L, Su Y, Xu M, Zhang M. A signature based on 11 autophagy genes for prognosis prediction of colorectal cancer. PLoS One 2021;16:e0258741. [PMID: 34699544 DOI: 10.1371/journal.pone.0258741] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
278 Jia S, Xu X, Zhou S, Chen Y, Ding G, Cao L. Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways. Cell Death Dis 2019;10:142. [PMID: 30760707 DOI: 10.1038/s41419-019-1366-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
279 Serna G, Ruiz-Pace F, Hernando J, Alonso L, Fasani R, Landolfi S, Comas R, Jimenez J, Elez E, Bullman S, Tabernero J, Capdevila J, Dienstmann R, Nuciforo P. Fusobacterium nucleatum persistence and risk of recurrence after preoperative treatment in locally advanced rectal cancer. Ann Oncol 2020;31:1366-75. [PMID: 32569727 DOI: 10.1016/j.annonc.2020.06.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
280 Rui M, Zhang X, Huang J, Wei D, Li Z, Shao Z, Ju H, Ren G. The baseline oral microbiota predicts the response of locally advanced oral squamous cell carcinoma patients to induction chemotherapy: A prospective longitudinal study. Radiother Oncol 2021;164:83-91. [PMID: 34571091 DOI: 10.1016/j.radonc.2021.09.013] [Reference Citation Analysis]
281 Zhang H, Lan M, Cui G, Zhu W. The Influence of Caerulomycin A on the Intestinal Microbiota in SD Rats. Mar Drugs 2020;18:E277. [PMID: 32456087 DOI: 10.3390/md18050277] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
282 Qin C, Liu Q, Hu ZW, Zhou LQ, Shang K, Bosco DB, Wu LJ, Tian DS, Wang W. Microglial TLR4-dependent autophagy induces ischemic white matter damage via STAT1/6 pathway. Theranostics 2018;8:5434-51. [PMID: 30555556 DOI: 10.7150/thno.27882] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
283 Peng C, Ouyang Y, Lu N, Li N. The NF-κB Signaling Pathway, the Microbiota, and Gastrointestinal Tumorigenesis: Recent Advances. Front Immunol 2020;11:1387. [PMID: 32695120 DOI: 10.3389/fimmu.2020.01387] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
284 Sanders BE, Umana A, Lemkul JA, Slade DJ. FusoPortal: an Interactive Repository of Hybrid MinION-Sequenced Fusobacterium Genomes Improves Gene Identification and Characterization. mSphere 2018;3:e00228-18. [PMID: 29976644 DOI: 10.1128/mSphere.00228-18] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
285 Lu Y, Wang L, Zhang J, Li J, Wan G. Induction of CD8 T cell cytotoxicity by fecal bacteria from healthy individuals and colorectal cancer patients. Biochem Biophys Res Commun. 2019;516:1007-1012. [PMID: 31277945 DOI: 10.1016/j.bbrc.2019.06.078] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
286 Liu CJ, Zhang YL, Shang Y, Wu B, Yang E, Luo YY, Li XR. Intestinal bacteria detected in cancer and adjacent tissue from patients with colorectal cancer. Oncol Lett 2019;17:1115-27. [PMID: 30655873 DOI: 10.3892/ol.2018.9714] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
287 Lee JB, Kim KA, Cho HY, Kim D, Kim WK, Yong D, Lee H, Yoon SS, Han DH, Han YD, Paik S, Jang M, Kim HS, Ahn JB. Association between Fusobacterium nucleatum and patient prognosis in metastatic colon cancer. Sci Rep 2021;11:20263. [PMID: 34642332 DOI: 10.1038/s41598-021-98941-6] [Reference Citation Analysis]
288 Devenport SN, Singhal R, Radyk MD, Taranto JG, Kerk SA, Chen B, Goyert JW, Jain C, Das NK, Oravecz-Wilson K, Zhang L, Greenson JK, Chen YE, Soleimanpour SA, Reddy P, Lyssiotis CA, Shah YM. Colorectal cancer cells utilize autophagy to maintain mitochondrial metabolism for cell proliferation under nutrient stress. JCI Insight 2021;6:138835. [PMID: 34138755 DOI: 10.1172/jci.insight.138835] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
289 Wong-Rolle A, Wei HK, Zhao C, Jin C. Unexpected guests in the tumor microenvironment: microbiome in cancer. Protein Cell 2021;12:426-35. [PMID: 33296049 DOI: 10.1007/s13238-020-00813-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
290 Liu Y, Chen YG. 2D- and 3D-Based Intestinal Stem Cell Cultures for Personalized Medicine. Cells 2018;7:E225. [PMID: 30469504 DOI: 10.3390/cells7120225] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
291 Eyvazi S, Vostakolaei MA, Dilmaghani A, Borumandi O, Hejazi MS, Kahroba H, Tarhriz V. The oncogenic roles of bacterial infections in development of cancer. Microb Pathog 2020;141:104019. [PMID: 32006638 DOI: 10.1016/j.micpath.2020.104019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
292 Fan Q, Shang F, Chen C, Zhou H, Fan J, Yang M, Nie X, Liu L, Cai K, Liu H. Microbial Characteristics of Locally Advanced Rectal Cancer Patients After Neoadjuvant Chemoradiation Therapy According to Pathologic Response. Cancer Manag Res 2021;13:2655-67. [PMID: 33776484 DOI: 10.2147/CMAR.S294936] [Reference Citation Analysis]
293 Liu J, Qu Y, Zheng T, Tian Y. A dual-mode nanoprobe for evaluation of the autophagy level affected by photothermal therapy. Chem Commun (Camb) 2019;55:9673-6. [PMID: 31342971 DOI: 10.1039/c9cc03319j] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
294 Song W, Anselmo AC, Huang L. Nanotechnology intervention of the microbiome for cancer therapy. Nat Nanotechnol 2019;14:1093-103. [DOI: 10.1038/s41565-019-0589-5] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 15.0] [Reference Citation Analysis]
295 Lu L, Zhuang T, Shao E, Liu Y, He H, Shu Z, Huang Y, Yao Y, Lin S, Lin S, Chen X, Chen X. Association of antibiotic exposure with the mortality in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy: A hospital-based retrospective cohort study. PLoS One 2019;14:e0221964. [PMID: 31504043 DOI: 10.1371/journal.pone.0221964] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
296 Jiang J, Mei J, Yi S, Feng C, Ma Y, Liu Y, Liu Y, Chen C. Tumor associated macrophage and microbe: The potential targets of tumor vaccine delivery. Adv Drug Deliv Rev 2021;180:114046. [PMID: 34767863 DOI: 10.1016/j.addr.2021.114046] [Reference Citation Analysis]
297 Nasir HM, Aris AZ, Abdullah LC, Ismail I. Facile fabrication and characterization of kenaf core as natural biochar for the highly efficient removal of selected endocrine-disrupting compounds. Environ Geochem Health 2021. [PMID: 34129136 DOI: 10.1007/s10653-021-00999-8] [Reference Citation Analysis]
298 Haruki K, Kosumi K, Hamada T, Twombly TS, Väyrynen JP, Kim SA, Masugi Y, Qian ZR, Mima K, Baba Y, da Silva A, Borowsky J, Arima K, Fujiyoshi K, Lau MC, Li P, Guo C, Chen Y, Song M, Nowak JA, Nishihara R, Yanaga K, Zhang X, Wu K, Bullman S, Garrett WS, Huttenhower C, Meyerhardt JA, Giannakis M, Chan AT, Fuchs CS, Ogino S. Association of autophagy status with amount of Fusobacterium nucleatum in colorectal cancer. J Pathol 2020;250:397-408. [PMID: 31880318 DOI: 10.1002/path.5381] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
299 Luo K, Zhang Y, Xv C, Ji J, Lou G, Guo X, Chen M, Zhang Y, Wei H, Guo M, Huang R, Yu S. Fusobacterium nucleatum, the communication with colorectal cancer. Biomed Pharmacother 2019;116:108988. [PMID: 31112873 DOI: 10.1016/j.biopha.2019.108988] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
300 Han T, Hu X, Li K, Zhang D, Zhang Y, Li J. Bifidobacterium infantis Maintains Genome Stability in Ulcerative Colitis via Regulating Anaphase-Promoting Complex Subunit 7. Front Microbiol 2021;12:761113. [PMID: 34795654 DOI: 10.3389/fmicb.2021.761113] [Reference Citation Analysis]
301 Zhao L, Xing C, Sun W, Hou G, Yang G, Yuan L. Lactobacillus supplementation prevents cisplatin-induced cardiotoxicity possibly by inflammation inhibition. Cancer Chemother Pharmacol 2018;82:999-1008. [DOI: 10.1007/s00280-018-3691-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
302 Kabwe M, Dashper S, Bachrach G, Tucci J. Bacteriophage manipulation of the microbiome associated with tumour microenvironments-can this improve cancer therapeutic response? FEMS Microbiol Rev 2021:fuab017. [PMID: 33765142 DOI: 10.1093/femsre/fuab017] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
303 Wu Y, Tang L, Wang B, Sun Q, Zhao P, Li W. The role of autophagy in maintaining intestinal mucosal barrier. J Cell Physiol 2019;234:19406-19. [PMID: 31020664 DOI: 10.1002/jcp.28722] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
304 Shafabakhsh R, Arianfar F, Vosough M, Mirzaei HR, Mahjoubin-Tehran M, Khanbabaei H, Kowsari H, Shojaie L, Azar MEF, Hamblin MR, Mirzaei H. Autophagy and gastrointestinal cancers: the behind the scenes role of long non-coding RNAs in initiation, progression, and treatment resistance. Cancer Gene Ther 2021. [PMID: 33432087 DOI: 10.1038/s41417-020-00272-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
305 Kang M, Kwok RTK, Wang J, Zhang H, Lam JWY, Li Y, Zhang P, Zou H, Gu X, Li F, Tang BZ. A multifunctional luminogen with aggregation-induced emission characteristics for selective imaging and photodynamic killing of both cancer cells and Gram-positive bacteria. J Mater Chem B 2018;6:3894-903. [PMID: 32254317 DOI: 10.1039/c8tb00572a] [Cited by in Crossref: 33] [Cited by in F6Publishing: 3] [Article Influence: 8.3] [Reference Citation Analysis]
306 Wu X, Zhang T, Chen X, Ji G, Zhang F. Microbiota transplantation: Targeting cancer treatment. Cancer Letters 2019;452:144-51. [DOI: 10.1016/j.canlet.2019.03.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
307 Morgillo F, Dallio M, Della Corte CM, Gravina AG, Viscardi G, Loguercio C, Ciardiello F, Federico A. Carcinogenesis as a Result of Multiple Inflammatory and Oxidative Hits: a Comprehensive Review from Tumor Microenvironment to Gut Microbiota. Neoplasia 2018;20:721-33. [PMID: 29859426 DOI: 10.1016/j.neo.2018.05.002] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 9.8] [Reference Citation Analysis]
308 Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y. Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct Target Ther 2020;5:28. [PMID: 32296047 DOI: 10.1038/s41392-020-0134-x] [Cited by in Crossref: 163] [Cited by in F6Publishing: 154] [Article Influence: 81.5] [Reference Citation Analysis]
309 Yang J, Li D, Yang Z, Dai W, Feng X, Liu Y, Jiang Y, Li P, Li Y, Tang B, Zhou Q, Qiu C, Zhang C, Xu X, Feng S, Wang D, Wang H, Wang W, Zheng Y, Zhang L, Wang W, Zhou K, Li S, Yu P. Establishing high-accuracy biomarkers for colorectal cancer by comparing fecal microbiomes in patients with healthy families. Gut Microbes 2020;11:918-29. [PMID: 31971861 DOI: 10.1080/19490976.2020.1712986] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
310 Huang Z, Liu Y, Wang L, Ali A, Yao Q, Jiang X, Gao Y. Supramolecular assemblies mimicking neutrophil extracellular traps for MRSE infection control. Biomaterials 2020;253:120124. [DOI: 10.1016/j.biomaterials.2020.120124] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
311 Roy BC, Ahmed I, Ramalingam S, Jala V, Haribabu B, Ramamoorthy P, Ashcraft J, Valentino J, Anant S, Sampath V, Umar S. Co-localization of autophagy-related protein p62 with cancer stem cell marker dclk1 may hamper dclk1's elimination during colon cancer development and progression. Oncotarget 2019;10:2340-54. [PMID: 31040926 DOI: 10.18632/oncotarget.26684] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
312 Xu P, Sun D, Gao Y, Jiang Y, Zhong M, Zhao G, Chen J, Wang Z, Liu Q, Hong J, Chen H, Chen YX, Fang JY. Germline mutations in a DNA repair pathway are associated with familial colorectal cancer. JCI Insight 2021;6:e148931. [PMID: 34549727 DOI: 10.1172/jci.insight.148931] [Reference Citation Analysis]
313 Inamura K. Colorectal Cancers: An Update on Their Molecular Pathology. Cancers (Basel). 2018;10. [PMID: 29361689 DOI: 10.3390/cancers10010026] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 15.5] [Reference Citation Analysis]
314 Carroll CSE, Andrew ER, Malik L, Elliott KF, Brennan M, Meyer J, Hintze A, Almonte AA, Lappin C, MacPherson P, Schulte KM, Dahlstrom JE, Tamhane R, Neeman T, Herbert EW, Orange M, Yip D, Allavena R, Fahrer AM. Simple and effective bacterial-based intratumoral cancer immunotherapy. J Immunother Cancer 2021;9:e002688. [PMID: 34531247 DOI: 10.1136/jitc-2021-002688] [Reference Citation Analysis]
315 Sun J, Feng D, Xi H, Luo J, Zhou Z, Liu Q, Chen Y, Shao Q. CD24 blunts the sensitivity of retinoblastoma to vincristine by modulating autophagy. Mol Oncol 2020;14:1740-59. [PMID: 32394616 DOI: 10.1002/1878-0261.12708] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
316 Xiao L, Zhang Q, Peng Y, Wang D, Liu Y. The effect of periodontal bacteria infection on incidence and prognosis of cancer: A systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e19698. [PMID: 32282725 DOI: 10.1097/MD.0000000000019698] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
317 Zhang H, Lu B. The Roles of ceRNAs-Mediated Autophagy in Cancer Chemoresistance and Metastasis. Cancers (Basel) 2020;12:E2926. [PMID: 33050642 DOI: 10.3390/cancers12102926] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
318 Zhao Y, Tao Q, Li S, Zheng P, Liu J, Liang X. Both endogenous and exogenous miR-139-5p inhibit Fusobacterium nucleatum-related colorectal cancer development. Eur J Pharmacol 2020;888:173459. [PMID: 32768506 DOI: 10.1016/j.ejphar.2020.173459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
319 Wei X, Mei C, Li X, Xie Y. The Unique Microbiome and Immunity in Pancreatic Cancer. Pancreas 2021;50:119-29. [DOI: 10.1097/mpa.0000000000001744] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
320 Wang X, Zhang A, Miao J, Sun H, Yan G, Wu F, Wang X. Gut microbiota as important modulator of metabolism in health and disease. RSC Adv 2018;8:42380-9. [DOI: 10.1039/c8ra08094a] [Cited by in Crossref: 37] [Cited by in F6Publishing: 1] [Article Influence: 9.3] [Reference Citation Analysis]
321 Jin Y, Geng R, Liu Y, Liu L, Jin X, Zhao F, Feng J, Wei Y. Prediction of Postoperative Ileus in Patients With Colorectal Cancer by Preoperative Gut Microbiota. Front Oncol 2020;10:526009. [PMID: 33324541 DOI: 10.3389/fonc.2020.526009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
322 Gorkiewicz G, Moschen A. Gut microbiome: a new player in gastrointestinal disease. Virchows Archiv : an international journal of pathology. 2018;472:159-172. [PMID: 29243124 DOI: 10.1007/s00428-017-2277-x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 7.4] [Reference Citation Analysis]
323 Wang D, Cheng J, Zhang J, Zhou F, He X, Shi Y, Tao Y. The Role of Respiratory Microbiota in Lung Cancer. Int J Biol Sci 2021;17:3646-58. [PMID: 34512172 DOI: 10.7150/ijbs.51376] [Reference Citation Analysis]
324 Gao ZY, Cui Z, Yan YQ, Ning LJ, Wang ZH, Hong J. Microbe-based management for colorectal cancer. Chin Med J (Engl) 2021;134:2922-30. [PMID: 34855639 DOI: 10.1097/CM9.0000000000001887] [Reference Citation Analysis]
325 Zhong Y, Lin H, Li Q, Liu C, Shen J. CircRNA_100565 contributes to cisplatin resistance of NSCLC cells by regulating proliferation, apoptosis and autophagy via miR-337-3p/ADAM28 axis. Cancer Biomark 2021;30:261-73. [PMID: 33682697 DOI: 10.3233/CBM-201705] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
326 Zaidi S, Rao S, Mishra L. Reply. Gastroenterology 2020;159:398-9. [PMID: 32289371 DOI: 10.1053/j.gastro.2020.04.009] [Reference Citation Analysis]
327 Le Noci V, Bernardo G, Bianchi F, Tagliabue E, Sommariva M, Sfondrini L. Toll Like Receptors as Sensors of the Tumor Microbial Dysbiosis: Implications in Cancer Progression. Front Cell Dev Biol 2021;9:732192. [PMID: 34604233 DOI: 10.3389/fcell.2021.732192] [Reference Citation Analysis]
328 Zhu XH, Lang HD, Wang XL, Hui SC, Zhou M, Kang C, Yi L, Mi MT, Zhang Y. Synergy between dihydromyricetin intervention and irinotecan chemotherapy delays the progression of colon cancer in mouse models. Food Funct 2019;10:2040-9. [PMID: 30907395 DOI: 10.1039/c8fo01756e] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
329 Lee MH. Harness the functions of gut microbiome in tumorigenesis for cancer treatment. Cancer Commun (Lond) 2021. [PMID: 34355542 DOI: 10.1002/cac2.12200] [Reference Citation Analysis]
330 Wang HC, Yeh TJ, Chan LP, Hsu CM, Cho SF. Exploration of Feasible Immune Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma Treatment in Real World Clinical Practice. Int J Mol Sci 2020;21:E7621. [PMID: 33076306 DOI: 10.3390/ijms21207621] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
331 Sarkar P, Malik S, Laha S, Das S, Bunk S, Ray JG, Chatterjee R, Saha A. Dysbiosis of Oral Microbiota During Oral Squamous Cell Carcinoma Development. Front Oncol 2021;11:614448. [PMID: 33708627 DOI: 10.3389/fonc.2021.614448] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
332 Advani SM, Advani P, DeSantis SM, Brown D, VonVille HM, Lam M, Loree JM, Mehrvarz Sarshekeh A, Bressler J, Lopez DS, Daniel CR, Swartz MD, Kopetz S. Clinical, Pathological, and Molecular Characteristics of CpG Island Methylator Phenotype in Colorectal Cancer: A Systematic Review and Meta-analysis. Transl Oncol. 2018;11:1188-1201. [PMID: 30071442 DOI: 10.1016/j.tranon.2018.07.008] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 7.5] [Reference Citation Analysis]
333 Zhang S, Yang Y, Weng W, Guo B, Cai G, Ma Y, Cai S. Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer. J Exp Clin Cancer Res 2019;38:14. [PMID: 30630498 DOI: 10.1186/s13046-018-0985-y] [Cited by in Crossref: 41] [Cited by in F6Publishing: 46] [Article Influence: 13.7] [Reference Citation Analysis]
334 Pandey K, Umar S. Microbiome in drug resistance to colon cancer. Curr Opin Physiol 2021;23:100472. [PMID: 34514218 DOI: 10.1016/j.cophys.2021.100472] [Reference Citation Analysis]
335 Richardson M, Ren J, Rubinstein MR, Taylor JA, Friedman RA, Shen B, Han YW. Analysis of 16S rRNA genes reveals reduced Fusobacterial community diversity when translocating from saliva to GI sites. Gut Microbes 2020;12:1-13. [PMID: 33054632 DOI: 10.1080/19490976.2020.1814120] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
336 Li M, Chen WD, Wang YD. The roles of the gut microbiota-miRNA interaction in the host pathophysiology. Mol Med 2020;26:101. [PMID: 33160314 DOI: 10.1186/s10020-020-00234-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
337 Irfan M, Delgado RZR, Frias-Lopez J. The Oral Microbiome and Cancer. Front Immunol 2020;11:591088. [PMID: 33193429 DOI: 10.3389/fimmu.2020.591088] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
338 Zuo T, Ng SC. The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory Bowel Disease. Front Microbiol. 2018;9:2247. [PMID: 30319571 DOI: 10.3389/fmicb.2018.02247] [Cited by in Crossref: 190] [Cited by in F6Publishing: 175] [Article Influence: 47.5] [Reference Citation Analysis]
339 Boussios S, Ozturk MA, Moschetta M, Karathanasi A, Zakynthinakis-Kyriakou N, Katsanos KH, Christodoulou DK, Pavlidis N. The Developing Story of Predictive Biomarkers in Colorectal Cancer. J Pers Med 2019;9:E12. [PMID: 30736475 DOI: 10.3390/jpm9010012] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 15.3] [Reference Citation Analysis]
340 Wang S, Wang W, Meng Q, Zhou S, Liu H, Ma X, Zhou X, Liu H, Chen X, Jiang W. Inferring Novel Autophagy Regulators Based on Transcription Factors and Non-Coding RNAs Coordinated Regulatory Network. Cells 2018;7:E194. [PMID: 30400235 DOI: 10.3390/cells7110194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
341 Yu J, Nong C, Zhao J, Meng L, Song J, Xie Z. An Integrative Bioinformatic Analysis of Microbiome and Transcriptome for Predicting the Risk of Colon Adenocarcinoma. Disease Markers 2022;2022:1-12. [DOI: 10.1155/2022/7994074] [Reference Citation Analysis]
342 Wu H, Huang W, Zhou X, Min Y. Immunological Effects of Aggregation-Induced Emission Materials. Front Immunol 2020;11:575816. [PMID: 33123158 DOI: 10.3389/fimmu.2020.575816] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
343 Zhang C, Wang J, Sun Z, Cao Y, Mu Z, Ji X. Commensal microbiota contributes to predicting the response to immune checkpoint inhibitors in non-small-cell lung cancer patients. Cancer Sci 2021;112:3005-17. [PMID: 34028936 DOI: 10.1111/cas.14979] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
344 Benedetti F, Cocchi F, Latinovic OS, Curreli S, Krishnan S, Munawwar A, Gallo RC, Zella D. Role of Mycoplasma Chaperone DnaK in Cellular Transformation. Int J Mol Sci 2020;21:E1311. [PMID: 32075244 DOI: 10.3390/ijms21041311] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
345 Yu MR, Kim HJ, Park HR. Fusobacterium nucleatum Accelerates the Progression of Colitis-Associated Colorectal Cancer by Promoting EMT. Cancers (Basel) 2020;12:E2728. [PMID: 32977534 DOI: 10.3390/cancers12102728] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
346 Qiu X, Zheng L, Liu X, Hong D, He M, Tang Z, Tian C, Tan G, Hwang S, Shi Z, Wang L. ULK1 Inhibition as a Targeted Therapeutic Strategy for Psoriasis by Regulating Keratinocytes and Their Crosstalk With Neutrophils. Front Immunol 2021;12:714274. [PMID: 34421918 DOI: 10.3389/fimmu.2021.714274] [Reference Citation Analysis]
347 Wang Y, Li J, Ma C, Jiang S, Li C, Zhang L, Zhang J. Lactiplantibacillus plantarum HNU082 inhibited the growth of Fusobacterium nucleatum and alleviated the inflammatory response introduced by F. nucleatum invasion. Food Funct 2021;12:10728-40. [PMID: 34608480 DOI: 10.1039/d1fo01388b] [Reference Citation Analysis]
348 Trivanović D, Pavelić K, Peršurić Ž. Fighting Cancer with Bacteria and Their Toxins. Int J Mol Sci 2021;22:12980. [PMID: 34884780 DOI: 10.3390/ijms222312980] [Reference Citation Analysis]
349 Wang S, Song X, Zhang K, Deng S, Jiao P, Qi M, Lian Z, Yao Y. Overexpression of Toll-Like Receptor 4 Affects Autophagy, Oxidative Stress, and Inflammatory Responses in Monocytes of Transgenic Sheep. Front Cell Dev Biol 2020;8:248. [PMID: 32432106 DOI: 10.3389/fcell.2020.00248] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
350 Guenther M, Haas M, Heinemann V, Kruger S, Westphalen CB, von Bergwelt-Baildon M, Mayerle J, Werner J, Kirchner T, Boeck S, Ormanns S. Bacterial lipopolysaccharide as negative predictor of gemcitabine efficacy in advanced pancreatic cancer - translational results from the AIO-PK0104 Phase 3 study. Br J Cancer 2020;123:1370-6. [PMID: 32830200 DOI: 10.1038/s41416-020-01029-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
351 Wu Y, Wang CZ, Wan JY, Yao H, Yuan CS. Dissecting the Interplay Mechanism between Epigenetics and Gut Microbiota: Health Maintenance and Disease Prevention. Int J Mol Sci 2021;22:6933. [PMID: 34203243 DOI: 10.3390/ijms22136933] [Reference Citation Analysis]
352 Song C, Qi H, Liu Y, Chen Y, Shi P, Zhang S, Ren J, Wang L, Cao Y, Sun H. Inhibition of lncRNA Gm15834 Attenuates Autophagy-Mediated Myocardial Hypertrophy via the miR-30b-3p/ULK1 Axis in Mice. Mol Ther 2021;29:1120-37. [PMID: 33130312 DOI: 10.1016/j.ymthe.2020.10.024] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
353 Cai Z, Wei Y, Chen S, Gong Y, Fu Y, Dai X, Zhou Y, Yang H, Tang L, Liu H. Screening and identification of key biomarkers in alimentary tract cancers: A bioinformatic analysis. Cancer Biomark 2020;29:221-33. [PMID: 32623389 DOI: 10.3233/CBM-201580] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
354 Montalban-Arques A, Scharl M. Intestinal microbiota and colorectal carcinoma: Implications for pathogenesis, diagnosis, and therapy. EBioMedicine 2019;48:648-55. [PMID: 31631043 DOI: 10.1016/j.ebiom.2019.09.050] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
355 Tong J, Zhang X, Fan Y, Chen L, Ma X, Yu H, Li J, Guan X, Zhao P, Yang J. Changes of Intestinal Microbiota in Ovarian Cancer Patients Treated with Surgery and Chemotherapy. Cancer Manag Res 2020;12:8125-35. [PMID: 32982410 DOI: 10.2147/CMAR.S265205] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
356 Yeoh Y, Low TY, Abu N, Lee PY. Regulation of signal transduction pathways in colorectal cancer: implications for therapeutic resistance. PeerJ 2021;9:e12338. [PMID: 34733591 DOI: 10.7717/peerj.12338] [Reference Citation Analysis]
357 Kang L, Liu S, Li J, Tian Y, Xue Y, Liu X. Parkin and Nrf2 prevent oxidative stress-induced apoptosis in intervertebral endplate chondrocytes via inducing mitophagy and anti-oxidant defenses. Life Sci 2020;243:117244. [PMID: 31891721 DOI: 10.1016/j.lfs.2019.117244] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
358 Sun W, Li J, Zhou L, Han J, Liu R, Zhang H, Ning T, Gao Z, Liu B, Chen X, Ba Y. The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer. Theranostics 2020;10:1981-96. [PMID: 32104496 DOI: 10.7150/thno.37621] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
359 Șurlin P, Nicolae FM, Șurlin VM, Pătrașcu Ș, Ungureanu BS, Didilescu AC, Gheonea DI. Could Periodontal Disease through Periopathogen Fusobacterium Nucleatum be an Aggravating Factor for Gastric Cancer? J Clin Med 2020;9:E3885. [PMID: 33260439 DOI: 10.3390/jcm9123885] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
360 Sun CH, Li BB, Wang B, Zhao J, Zhang XY, Li TT, Li WB, Tang D, Qiu MJ, Wang XC, Zhu CM, Qian ZR. The role of Fusobacterium nucleatum in colorectal cancer: from carcinogenesis to clinical management. Chronic Dis Transl Med 2019;5:178-87. [PMID: 31891129 DOI: 10.1016/j.cdtm.2019.09.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 7.7] [Reference Citation Analysis]
361 Mukherji R, Weinberg BA. The gut microbiome and potential implications for early-onset colorectal cancer. Colorectal Cancer 2020;9:CRC25. [DOI: 10.2217/crc-2020-0007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
362 Watson KM, Gaulke CA, Tsikitis VL. Understanding the microbiome: a primer on the role of the microbiome in colorectal neoplasia. Ann Gastroenterol 2020;33:223-36. [PMID: 32382225 DOI: 10.20524/aog.2020.0467] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
363 Qu J, Sun Z, Peng C, Li D, Yan W, Xu Z, Hou Y, Shen S, Chen P, Wang T. C. tropicalis promotes chemotherapy resistance in colon cancer through increasing lactate production to regulate the mismatch repair system. Int J Biol Sci 2021;17:2756-69. [PMID: 34345205 DOI: 10.7150/ijbs.59262] [Reference Citation Analysis]
364 Wen L, Mu W, Lu H, Wang X, Fang J, Jia Y, Li Q, Wang D, Wen S, Guo J, Dai W, Ren X, Cui J, Zeng G, Gao J, Wang Z, Cheng B. Porphyromonas gingivalis Promotes Oral Squamous Cell Carcinoma Progression in an Immune Microenvironment. J Dent Res 2020;99:666-75. [DOI: 10.1177/0022034520909312] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
365 Ashrafizadeh M, Zarrabi A, Hushmandi K, Kalantari M, Mohammadinejad R, Javaheri T, Sethi G. Association of the Epithelial-Mesenchymal Transition (EMT) with Cisplatin Resistance. Int J Mol Sci 2020;21:E4002. [PMID: 32503307 DOI: 10.3390/ijms21114002] [Cited by in Crossref: 38] [Cited by in F6Publishing: 46] [Article Influence: 19.0] [Reference Citation Analysis]
366 Sun J, Tang Q, Yu S, Xie M, Xie Y, Chen G, Chen L. Role of the oral microbiota in cancer evolution and progression. Cancer Med 2020;9:6306-21. [PMID: 32638533 DOI: 10.1002/cam4.3206] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
367 Xue Y, Xiao H, Guo S, Xu B, Liao Y, Wu Y, Zhang G. Indoleamine 2,3-dioxygenase expression regulates the survival and proliferation of Fusobacterium nucleatum in THP-1-derived macrophages. Cell Death Dis 2018;9:355. [PMID: 29500439 DOI: 10.1038/s41419-018-0389-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
368 Nizam W, Yeo HL, Obeng-Gyasi S, Brock MV, Johnston FM. Disparities in Surgical Oncology: Management of Advanced Cancer. Ann Surg Oncol 2021. [PMID: 34268636 DOI: 10.1245/s10434-021-10275-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
369 McIlvanna E, Linden GJ, Craig SG, Lundy FT, James JA. Fusobacterium nucleatum and oral cancer: a critical review. BMC Cancer 2021;21:1212. [PMID: 34774023 DOI: 10.1186/s12885-021-08903-4] [Reference Citation Analysis]
370 Shang AQ, Wang WW, Yang YB, Gu CZ, Ji P, Chen C, Zeng BJ, Wu JL, Lu WY, Sun ZJ, Li D. Knockdown of long noncoding RNA PVT1 suppresses cell proliferation and invasion of colorectal cancer via upregulation of microRNA-214-3p. Am J Physiol Gastrointest Liver Physiol 2019;317:G222-32. [PMID: 31125260 DOI: 10.1152/ajpgi.00357.2018] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 11.3] [Reference Citation Analysis]
371 Brennan CA, Nakatsu G, Gallini Comeau CA, Drew DA, Glickman JN, Schoen RE, Chan AT, Garrett WS. Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum. mBio 2021;12:e00547-21. [PMID: 33824205 DOI: 10.1128/mBio.00547-21] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
372 He X, Yang Y, Guo Y, Lu S, Du Y, Li JJ, Zhang X, Leung NLC, Zhao Z, Niu G, Yang S, Weng Z, Kwok RTK, Lam JWY, Xie G, Tang BZ. Phage-Guided Targeting, Discriminative Imaging, and Synergistic Killing of Bacteria by AIE Bioconjugates. J Am Chem Soc 2020;142:3959-69. [PMID: 31999445 DOI: 10.1021/jacs.9b12936] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 21.5] [Reference Citation Analysis]
373 Liang J, Jia X, Wang K, Zhao N. High expression of TFEB is associated with aggressive clinical features in colorectal cancer. Onco Targets Ther 2018;11:8089-98. [PMID: 30519051 DOI: 10.2147/OTT.S180112] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
374 Loftus M, Hassouneh SA, Yooseph S. Bacterial community structure alterations within the colorectal cancer gut microbiome. BMC Microbiol 2021;21:98. [PMID: 33789570 DOI: 10.1186/s12866-021-02153-x] [Reference Citation Analysis]
375 Sánchez-Alcoholado L, Ramos-Molina B, Otero A, Laborda-Illanes A, Ordóñez R, Medina JA, Gómez-Millán J, Queipo-Ortuño MI. The Role of the Gut Microbiome in Colorectal Cancer Development and Therapy Response. Cancers (Basel) 2020;12:E1406. [PMID: 32486066 DOI: 10.3390/cancers12061406] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 17.0] [Reference Citation Analysis]
376 Liu H, Hong XL, Sun TT, Huang XW, Wang JL, Xiong H. Fusobacterium nucleatum exacerbates colitis by damaging epithelial barriers and inducing aberrant inflammation. J Dig Dis 2020;21:385-98. [DOI: 10.1111/1751-2980.12909] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
377 Huang X, Hong X, Wang J, Sun T, Yu T, Yu Y, Fang J, Xiong H. Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis. EBioMedicine 2020;61:103037. [PMID: 33039709 DOI: 10.1016/j.ebiom.2020.103037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
378 Kong C, Gao R, Yan X, Huang L, He J, Li H, You J, Qin H. Alterations in intestinal microbiota of colorectal cancer patients receiving radical surgery combined with adjuvant CapeOx therapy. Sci China Life Sci 2019;62:1178-93. [PMID: 30796721 DOI: 10.1007/s11427-018-9456-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
379 Smet A, Kupcinskas J, Link A, Hold GL, Bornschein J. The Role of Microbiota in Gastrointestinal Cancer and Cancer Treatment - Chance or Curse? Cell Mol Gastroenterol Hepatol 2021:S2352-345X(21)00180-6. [PMID: 34506954 DOI: 10.1016/j.jcmgh.2021.08.013] [Reference Citation Analysis]
380 Zhang WC. microRNAs Tune Oxidative Stress in Cancer Therapeutic Tolerance and Resistance. Int J Mol Sci 2019;20:E6094. [PMID: 31816897 DOI: 10.3390/ijms20236094] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
381 Brandi G, Frega G. Microbiota: Overview and Implication in Immunotherapy-Based Cancer Treatments. Int J Mol Sci 2019;20:E2699. [PMID: 31159348 DOI: 10.3390/ijms20112699] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
382 Bao X, Weiner J 3rd, Meckes O, Dommisch H, Schaefer AS. Entamoeba gingivalis Exerts Severe Pathogenic Effects on the Oral Mucosa. J Dent Res 2021;100:771-6. [PMID: 33792418 DOI: 10.1177/00220345211004498] [Reference Citation Analysis]
383 Jobin C. Human Intestinal Microbiota and Colorectal Cancer: Moving Beyond Associative Studies. Gastroenterology 2017;153:1475-8. [PMID: 29100848 DOI: 10.1053/j.gastro.2017.10.030] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
384 Ternes D, Karta J, Tsenkova M, Wilmes P, Haan S, Letellier E. Microbiome in Colorectal Cancer: How to Get from Meta-omics to Mechanism? Trends Microbiol. 2020;28:401-423. [PMID: 32298617 DOI: 10.1016/j.tim.2020.01.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 18.0] [Reference Citation Analysis]
385 Xiao T, Wu S, Yan C, Zhao C, Jin H, Yan N, Xu J, Wu Y, Li C, Shao Q, Xia S. Butyrate upregulates the TLR4 expression and the phosphorylation of MAPKs and NK-κB in colon cancer cell in vitro. Oncol Lett 2018;16:4439-47. [PMID: 30214578 DOI: 10.3892/ol.2018.9201] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
386 Vergara D, Simeone P, Damato M, Maffia M, Lanuti P, Trerotola M. The Cancer Microbiota: EMT and Inflammation as Shared Molecular Mechanisms Associated with Plasticity and Progression. J Oncol 2019;2019:1253727. [PMID: 31772577 DOI: 10.1155/2019/1253727] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 7.7] [Reference Citation Analysis]
387 Yu Z, Wang Y, Wang B, Zhai J. Metformin Affects Paclitaxel Sensitivity of Ovarian Cancer Cells Through Autophagy Mediated by Long Noncoding RNASNHG7/miR-3127-5p Axis. Cancer Biother Radiopharm 2020. [PMID: 32522016 DOI: 10.1089/cbr.2019.3390] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
388 Lee SA, Liu F, Riordan SM, Lee CS, Zhang L. Global Investigations of Fusobacterium nucleatum in Human Colorectal Cancer. Front Oncol 2019;9:566. [PMID: 31334107 DOI: 10.3389/fonc.2019.00566] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
389 Han S, Zhuang J, Wu Y, Wu W, Yang X. Progress in Research on Colorectal Cancer-Related Microorganisms and Metabolites. Cancer Manag Res 2020;12:8703-20. [PMID: 33061569 DOI: 10.2147/CMAR.S268943] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
390 Mazzarella L, Duso BA, Trapani D, Belli C, D'amico P, Ferraro E, Viale G, Curigliano G. The evolving landscape of ‘next-generation’ immune checkpoint inhibitors: A review. European Journal of Cancer 2019;117:14-31. [DOI: 10.1016/j.ejca.2019.04.035] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 13.0] [Reference Citation Analysis]
391 Li Q, Lai Q, He C, Zhang H, Pan X, Li H, Yan Q, Fang Y, Liu S, Li A. RUNX1 regulates the proliferation and chemoresistance of colorectal cancer through the Hedgehog signaling pathway. J Cancer 2021;12:6363-71. [PMID: 34659526 DOI: 10.7150/jca.51338] [Reference Citation Analysis]
392 Allen J, Sears CL. Impact of the gut microbiome on the genome and epigenome of colon epithelial cells: contributions to colorectal cancer development. Genome Med. 2019;11:11. [PMID: 30803449 DOI: 10.1186/s13073-019-0621-2] [Cited by in Crossref: 60] [Cited by in F6Publishing: 55] [Article Influence: 20.0] [Reference Citation Analysis]
393 Wang L, Tang L, Feng Y, Zhao S, Han M, Zhang C, Yuan G, Zhu J, Cao S, Wu Q, Li L, Zhang Z. A purified membrane protein from Akkermansia muciniphila or the pasteurised bacterium blunts colitis associated tumourigenesis by modulation of CD8+ T cells in mice. Gut. 2020;69:1988-1997. [PMID: 32169907 DOI: 10.1136/gutjnl-2019-320105] [Cited by in Crossref: 41] [Cited by in F6Publishing: 49] [Article Influence: 20.5] [Reference Citation Analysis]
394 Bridges KM, Greiner KA, Umar S. Deciphering the Colorectal Cancer Gut Microbiota: Association vs. Causality. Curr Colorectal Cancer Rep 2019;15:70-7. [DOI: 10.1007/s11888-019-00431-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
395 Lapaquette P, Bizeau JB, Acar N, Bringer MA. Reciprocal interactions between gut microbiota and autophagy. World J Gastroenterol 2021; 27(48): 8283-8301 [DOI: 10.3748/wjg.v27.i48.8283] [Reference Citation Analysis]
396 Chen Y, Yang T, Chen S, Qi S, Zhang Z, Xu Y. Silver nanoparticles regulate autophagy through lysosome injury and cell hypoxia in prostate cancer cells. J Biochem Mol Toxicol 2020;34:e22474. [PMID: 32043710 DOI: 10.1002/jbt.22474] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
397 Oliva M, Spreafico A, Taberna M, Alemany L, Coburn B, Mesia R, Siu LL. Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma. Ann Oncol 2019;30:57-67. [PMID: 30462163 DOI: 10.1093/annonc/mdy507] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 28.0] [Reference Citation Analysis]
398 Sánchez-Alcoholado L, Laborda-Illanes A, Otero A, Ordóñez R, González-González A, Plaza-Andrades I, Ramos-Molina B, Gómez-Millán J, Queipo-Ortuño MI. Relationships of Gut Microbiota Composition, Short-Chain Fatty Acids and Polyamines with the Pathological Response to Neoadjuvant Radiochemotherapy in Colorectal Cancer Patients. Int J Mol Sci 2021;22:9549. [PMID: 34502456 DOI: 10.3390/ijms22179549] [Reference Citation Analysis]
399 Javed I, Cui X, Wang X, Mortimer M, Andrikopoulos N, Li Y, Davis TP, Zhao Y, Ke PC, Chen C. Implications of the Human Gut–Brain and Gut–Cancer Axes for Future Nanomedicine. ACS Nano 2020;14:14391-416. [DOI: 10.1021/acsnano.0c07258] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
400 Yamamura K, Izumi D, Kandimalla R, Sonohara F, Baba Y, Yoshida N, Kodera Y, Baba H, Goel A. Intratumoral Fusobacterium Nucleatum Levels Predict Therapeutic Response to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma. Clin Cancer Res 2019;25:6170-9. [PMID: 31358543 DOI: 10.1158/1078-0432.CCR-19-0318] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 8.7] [Reference Citation Analysis]
401 Wang X, Zhang X, Yuan J, Wu J, Deng X, Peng J, Wang S, Yang C, Ge J, Zou Y. Evaluation of the performance of serum miRNAs as normalizers in microRNA studies focused on cardiovascular disease. J Thorac Dis 2018;10:2599-607. [PMID: 29997921 DOI: 10.21037/jtd.2018.04.128] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
402 Liu J, Liu C, Yue J. Radiotherapy and the gut microbiome: facts and fiction. Radiat Oncol 2021;16:9. [PMID: 33436010 DOI: 10.1186/s13014-020-01735-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
403 Malik SA, Zhu C, Li J, LaComb JF, Denoya PI, Kravets I, Miller JD, Yang J, Kramer M, McCombie WR, Robertson CE, Frank DN, Li E. Impact of preoperative antibiotics and other variables on integrated microbiome-host transcriptomic data generated from colorectal cancer resections. World J Gastroenterol 2021; 27(14): 1465-1482 [PMID: 33911468 DOI: 10.3748/wjg.v27.i14.1465] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
404 Puschhof J, Pleguezuelos-Manzano C, Clevers H. Organoids and organs-on-chips: Insights into human gut-microbe interactions. Cell Host Microbe 2021;29:867-78. [PMID: 34111395 DOI: 10.1016/j.chom.2021.04.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
405 Xiao-Pei H, Ji-Kuai C, Xue W, Dong YF, Yan L, Xiao-Fang Z, Ya-Min P, Wen-Jun C, Jiang-Bo Z. Systematic identification of Celastrol-binding proteins reveals that Shoc2 is inhibited by Celastrol. Biosci Rep 2018;38:BSR20181233. [PMID: 30333251 DOI: 10.1042/BSR20181233] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
406 Jin M, Shang F, Wu J, Fan Q, Chen C, Fan J, Liu L, Nie X, Zhang T, Cai K, Ogino S, Liu H. Tumor-Associated Microbiota in Proximal and Distal Colorectal Cancer and Their Relationships With Clinical Outcomes. Front Microbiol 2021;12:727937. [PMID: 34650531 DOI: 10.3389/fmicb.2021.727937] [Reference Citation Analysis]
407 Liu K, Yang X, Zeng M, Yuan Y, Sun J, He P, Sun J, Xie Q, Chang X, Zhang S, Chen X, Cai L, Xie Y, Jiao X. The Role of Fecal Fusobacterium nucleatum and pks+ Escherichia coli as Early Diagnostic Markers of Colorectal Cancer. Dis Markers 2021;2021:1171239. [PMID: 34853619 DOI: 10.1155/2021/1171239] [Reference Citation Analysis]
408 Proença MA, Biselli JM, Succi M, Severino FE, Berardinelli GN, Caetano A, Reis RM, Hughes DJ, Silva AE. Relationship between Fusobacterium nucleatum, inflammatory mediators and microRNAs in colorectal carcinogenesis. World J Gastroenterol 2018; 24(47): 5351-5365 [PMID: 30598580 DOI: 10.3748/wjg.v24.i47.5351] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
409 Kalasabail S, Engelman J, Zhang LY, El-Omar E, Yim HCH. A Perspective on the Role of Microbiome for Colorectal Cancer Treatment. Cancers (Basel) 2021;13:4623. [PMID: 34572850 DOI: 10.3390/cancers13184623] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
410 Sui H, Zhang L, Gu K, Chai N, Ji Q, Zhou L, Wang Y, Ren J, Yang L, Zhang B, Hu J, Li Q. YYFZBJS ameliorates colorectal cancer progression in ApcMin/+ mice by remodeling gut microbiota and inhibiting regulatory T-cell generation. Cell Commun Signal 2020;18:113. [PMID: 32677955 DOI: 10.1186/s12964-020-00596-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
411 Sun L, Zhang Y, Chen W, Lan T, Wang Y, Wu Y, Liao X, Mi J. The Dynamic Changes of Gut Microbiota during the Perinatal Period in Sows. Animals (Basel) 2020;10:E2254. [PMID: 33266170 DOI: 10.3390/ani10122254] [Reference Citation Analysis]
412 Van der Merwe M, Van Niekerk G, Botha A, Engelbrecht AM. The onco-immunological implications of Fusobacterium nucleatum in breast cancer. Immunol Lett 2021;232:60-6. [PMID: 33647328 DOI: 10.1016/j.imlet.2021.02.007] [Reference Citation Analysis]
413 Garajová I, Balsano R, Wang H, Leonardi F, Giovannetti E, Deng D, Peters GJ. The role of the microbiome in drug resistance in gastrointestinal cancers. Expert Rev Anticancer Ther 2021;21:165-76. [PMID: 33115280 DOI: 10.1080/14737140.2021.1844007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
414 Kim S, Lee JY, Shin SG, Kim JK, Silwal P, Kim YJ, Shin NR, Kim PS, Won M, Lee SH, Kim SY, Sasai M, Yamamoto M, Kim JM, Bae JW, Jo EK. ESRRA (estrogen related receptor alpha) is a critical regulator of intestinal homeostasis through activation of autophagic flux via gut microbiota. Autophagy 2020;:1-20. [PMID: 33172329 DOI: 10.1080/15548627.2020.1847460] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
415 Hamada T, Zhang X, Mima K, Bullman S, Sukawa Y, Nowak JA, Kosumi K, Masugi Y, Twombly TS, Cao Y, Song M, Liu L, da Silva A, Shi Y, Gu M, Li W, Koh H, Nosho K, Inamura K, Keum N, Wu K, Meyerhardt JA, Kostic AD, Huttenhower C, Garrett WS, Meyerson M, Giovannucci EL, Chan AT, Fuchs CS, Nishihara R, Giannakis M, Ogino S. Fusobacterium nucleatum in Colorectal Cancer Relates to Immune Response Differentially by Tumor Microsatellite Instability Status. Cancer Immunol Res 2018;6:1327-36. [PMID: 30228205 DOI: 10.1158/2326-6066.CIR-18-0174] [Cited by in Crossref: 51] [Cited by in F6Publishing: 40] [Article Influence: 12.8] [Reference Citation Analysis]
416 Guevarra LA Jr, Afable ACF, Belza PJO, Dy KJS, Lee SJQ, Sy-Ortin TT, Albano PMSP. Immunogenicity of a Fap2 peptide mimotope of Fusobacterium nucleatum and its potential use in the diagnosis of colorectal cancer. Infect Agent Cancer 2018;13:11. [PMID: 29619076 DOI: 10.1186/s13027-018-0184-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
417 Nie S, Wang A, Yuan Y. Comparison of clinicopathological parameters, prognosis, micro-ecological environment and metabolic function of Gastric Cancer with or without Fusobacterium sp. Infection. J Cancer 2021;12:1023-32. [PMID: 33442401 DOI: 10.7150/jca.50918] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
418 Ryu G, Kim H, Koh A. Approaching precision medicine by tailoring the microbiota. Mamm Genome 2021;32:206-22. [PMID: 33646347 DOI: 10.1007/s00335-021-09859-3] [Reference Citation Analysis]
419 Guven DC, Dizdar O, Alp A, Akdoğan Kittana FN, Karakoc D, Hamaloglu E, Lacin S, Karakas Y, Kilickap S, Hayran M, Yalcin S. Analysis of Fusobacterium nucleatum and Streptococcus gallolyticus in saliva of colorectal cancer patients. Biomark Med 2019;13:725-35. [PMID: 31157977 DOI: 10.2217/bmm-2019-0020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
420 Yu TC, Zhou YL, Fang JY. Oral pathogen in the pathogenesis of colorectal cancer. J Gastroenterol Hepatol 2021. [PMID: 34837266 DOI: 10.1111/jgh.15743] [Reference Citation Analysis]
421 Hernández-Luna MA, López-Briones S, Luria-Pérez R. The Four Horsemen in Colon Cancer. J Oncol 2019;2019:5636272. [PMID: 31662752 DOI: 10.1155/2019/5636272] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
422 Innao V, Allegra AG, Musolino C, Allegra A. New Frontiers about the Role of Human Microbiota in Immunotherapy: The Immune Checkpoint Inhibitors and CAR T-Cell Therapy Era. Int J Mol Sci 2020;21:E8902. [PMID: 33255336 DOI: 10.3390/ijms21238902] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
423 Tang W, Liu ZY, Abreu C. Fusobacterium nucleatum Pleural Empyema in a Patient with Progressive Rheumatoid Arthritis and Immunosuppression. Case Rep Infect Dis 2021;2021:5212401. [PMID: 34336316 DOI: 10.1155/2021/5212401] [Reference Citation Analysis]
424 Fujiwara N, Kitamura N, Yoshida K, Yamamoto T, Ozaki K, Kudo Y. Involvement of Fusobacterium Species in Oral Cancer Progression: A Literature Review Including Other Types of Cancer. Int J Mol Sci 2020;21:E6207. [PMID: 32867334 DOI: 10.3390/ijms21176207] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
425 Qi YJ, Jiao YL, Chen P, Kong JY, Gu BL, Liu K, Feng DD, Zhu YF, Ruan HJ, Lan ZJ, Liu QW, Mi YJ, Guo XQ, Wang M, Liang GF, Lamont RJ, Wang H, Zhou FY, Feng XS, Gao SG. Porphyromonas gingivalis promotes progression of esophageal squamous cell cancer via TGFβ-dependent Smad/YAP/TAZ signaling. PLoS Biol 2020;18:e3000825. [PMID: 32886690 DOI: 10.1371/journal.pbio.3000825] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
426 Cao Y. Adipocyte and lipid metabolism in cancer drug resistance. J Clin Invest 2019;129:3006-17. [PMID: 31264969 DOI: 10.1172/JCI127201] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 18.3] [Reference Citation Analysis]
427 Salesse L, Lucas C, Hoang MHT, Sauvanet P, Rezard A, Rosenstiel P, Damon-Soubeyrand C, Barnich N, Godfraind C, Dalmasso G, Nguyen HTT. Colibactin-Producing Escherichia coli Induce the Formation of Invasive Carcinomas in a Chronic Inflammation-Associated Mouse Model. Cancers (Basel) 2021;13:2060. [PMID: 33923277 DOI: 10.3390/cancers13092060] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
428 Miyamoto Y, Hiyoshi Y, Sawayama H, Tokunaga R, Baba H. Precision medicine for adjuvant chemotherapy of resected colorectal cancer. Ann Gastroenterol Surg 2020;4:635-45. [PMID: 33319153 DOI: 10.1002/ags3.12397] [Reference Citation Analysis]
429 Anfossi S, Calin GA. Gut microbiota: a new player in regulating immune- and chemo-therapy efficacy. Cancer Drug Resist 2020;3:356-70. [PMID: 33062956 DOI: 10.20517/cdr.2020.04] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
430 Kumar M, Singh P, Murugesan S, Vetizou M, McCulloch J, Badger JH, Trinchieri G, Al Khodor S. Microbiome as an Immunological Modifier. Methods Mol Biol 2020;2055:595-638. [PMID: 31502171 DOI: 10.1007/978-1-4939-9773-2_27] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
431 Dumont-Leblond N, Veillette M, Racine C, Joubert P, Duchaine C. Non-small cell lung cancer microbiota characterization: Prevalence of enteric and potentially pathogenic bacteria in cancer tissues. PLoS One 2021;16:e0249832. [PMID: 33891617 DOI: 10.1371/journal.pone.0249832] [Reference Citation Analysis]
432 Ding C, Tang W, Fan X, Wu G. Intestinal microbiota: a novel perspective in colorectal cancer biotherapeutics. Onco Targets Ther 2018;11:4797-810. [PMID: 30147331 DOI: 10.2147/OTT.S170626] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 5.8] [Reference Citation Analysis]
433 Pourhanifeh MH, Vosough M, Mahjoubin-tehran M, Hashemipour M, Nejati M, Abbasi-kolli M, Sahebkar A, Mirzaei H. Autophagy-related microRNAs: Possible regulatory roles and therapeutic potential in and gastrointestinal cancers. Pharmacological Research 2020;161:105133. [DOI: 10.1016/j.phrs.2020.105133] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 11.0] [Reference Citation Analysis]
434 Hamada T, Nowak JA, Milner DA jr. Song M, Ogino S. Integration of microbiology, molecular pathology, and epidemiology: a new paradigm to explore the pathogenesis of microbiome-driven neoplasms. J Pathol. 2019;247:615-628. [PMID: 30632609 DOI: 10.1002/path.5236] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 16.0] [Reference Citation Analysis]
435 Zhou Z, Chen J, Yao H, Hu H. Fusobacterium and Colorectal Cancer. Front Oncol. 2018;8:371. [PMID: 30374420 DOI: 10.3389/fonc.2018.00371] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 11.8] [Reference Citation Analysis]
436 Newsome RC, Yang Y, Jobin C. The microbiome, gastrointestinal cancer, and immunotherapy. J Gastroenterol Hepatol 2021. [PMID: 34820895 DOI: 10.1111/jgh.15742] [Reference Citation Analysis]
437 Kumar P, Jagtap YA, Patwa SM, Kinger S, Dubey AR, Prajapati VK, Dhiman R, Poluri KM, Mishra A. Autophagy based cellular physiological strategies target oncogenic progression. J Cell Physiol 2021. [PMID: 34448206 DOI: 10.1002/jcp.30567] [Reference Citation Analysis]
438 Huang P, Zhu S, Liang X, Zhang Q, Luo X, Liu C, Song L. Regulatory Mechanisms of LncRNAs in Cancer Glycolysis: Facts and Perspectives. Cancer Manag Res 2021;13:5317-36. [PMID: 34262341 DOI: 10.2147/CMAR.S314502] [Reference Citation Analysis]
439 Tian L, Zhao Z, Xie L, Zhu J. MiR-361-5p suppresses chemoresistance of gastric cancer cells by targeting FOXM1 via the PI3K/Akt/mTOR pathway. Oncotarget 2018;9:4886-96. [PMID: 29435149 DOI: 10.18632/oncotarget.23513] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
440 Inamura K. Gut microbiota contributes towards immunomodulation against cancer: New frontiers in precision cancer therapeutics. Semin Cancer Biol 2021;70:11-23. [PMID: 32580023 DOI: 10.1016/j.semcancer.2020.06.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
441 LaCourse KD, Johnston CD, Bullman S. The relationship between gastrointestinal cancers and the microbiota. Lancet Gastroenterol Hepatol 2021;6:498-509. [PMID: 33743198 DOI: 10.1016/S2468-1253(20)30362-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
442 Gao R, Zhu Y, Kong C, Xia K, Li H, Zhu Y, Zhang X, Liu Y, Zhong H, Yang R, Chen C, Qin N, Qin H. Alterations, Interactions, and Diagnostic Potential of Gut Bacteria and Viruses in Colorectal Cancer. Front Cell Infect Microbiol 2021;11:657867. [PMID: 34307189 DOI: 10.3389/fcimb.2021.657867] [Reference Citation Analysis]
443 Wu MX, Wang SH, Xie Y, Chen ZT, Guo Q, Yuan WL, Guan C, Xu CZ, Huang YN, Wang JF, Zhang HF, Chen YX. Interleukin-33 alleviates diabetic cardiomyopathy through regulation of endoplasmic reticulum stress and autophagy via insulin-like growth factor-binding protein 3. J Cell Physiol 2021;236:4403-19. [PMID: 33184863 DOI: 10.1002/jcp.30158] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
444 Chen B, Du G, Guo J, Zhang Y. Bugs, drugs, and cancer: can the microbiome be a potential therapeutic target for cancer management? Drug Discov Today 2019;24:1000-9. [PMID: 30818030 DOI: 10.1016/j.drudis.2019.02.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
445 Cui X, Liang Z, Lu J, Wang X, Jia F, Hu Q, Xiao X, Deng X, Wu Y, Sheng W. A multifunctional nanodiamond-based nanoplatform for the enhanced mild-temperature photothermal/chemo combination therapy of triple negative breast cancer via an autophagy regulation strategy. Nanoscale 2021;13:13375-89. [PMID: 34477743 DOI: 10.1039/d1nr03161a] [Reference Citation Analysis]
446 Sayed IM, El-Hafeez AAA, Maity PP, Das S, Ghosh P. Modeling colorectal cancers using multidimensional organoids. Adv Cancer Res 2021;151:345-83. [PMID: 34148617 DOI: 10.1016/bs.acr.2021.02.005] [Reference Citation Analysis]
447 Liu CZ, Chen W, Wang MX, Wang Y, Chen LQ, Zhao F, Shi Y, Liu HJ, Dou XB, Liu C, Chen H. Dendrobium officinale Kimura et Migo and American ginseng mixture: A Chinese herbal formulation for gut microbiota modulation. Chin J Nat Med 2020;18:446-59. [PMID: 32503736 DOI: 10.1016/S1875-5364(20)30052-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
448 Fan R, Li Z, Shi X, Wang L, Zhang X, Dong Y, Quan C. Expression, Purification, and Characterization of the Recombinant, Two-Component, Response Regulator ArlR from Fusobacterium nucleatum. Appl Biochem Biotechnol. [DOI: 10.1007/s12010-021-03785-5] [Reference Citation Analysis]
449 Li L, Yao W, Yan S, Dong X, Lv Z, Jing Q, Wang Q, Ma B, Hao C, Xue D, Wang D. Pan-Cancer Analysis of Prognostic and Immune Infiltrates for CXCs. Cancers (Basel) 2021;13:4153. [PMID: 34439306 DOI: 10.3390/cancers13164153] [Reference Citation Analysis]
450 Wang S, Feng W, Wang W, Ye X, Chen H, Yu C. Girdin Knockdown Increases Gemcitabine Chemosensitivity to Pancreatic Cancer by Modulating Autophagy. Front Oncol 2021;11:618764. [PMID: 33854963 DOI: 10.3389/fonc.2021.618764] [Reference Citation Analysis]
451 Li C, Liu F, Yang X, Guo B, Li G, Yin J, He G, Yang C, Xu L, Li S, Wu H, Liu H, Ruan Y, Gu J, Wang L. Targeting lectin-like oxidized low-density lipoprotein receptor-1 triggers autophagic program in esophageal cancer. Cell Death Differ 2021. [PMID: 34611296 DOI: 10.1038/s41418-021-00884-y] [Reference Citation Analysis]
452 Liang JQ, Li T, Nakatsu G, Chen YX, Yau TO, Chu E, Wong S, Szeto CH, Ng SC, Chan FKL, Fang JY, Sung JJY, Yu J. A novel faecal Lachnoclostridium marker for the non-invasive diagnosis of colorectal adenoma and cancer. Gut 2020;69:1248-57. [PMID: 31776231 DOI: 10.1136/gutjnl-2019-318532] [Cited by in Crossref: 29] [Cited by in F6Publishing: 35] [Article Influence: 9.7] [Reference Citation Analysis]
453 Chen YC, Miao ZF, Yip KL, Cheng YA, Liu CJ, Li LH, Lin CY, Wang JW, Wu DC, Cheng TL, Wang JY. Gut Fecal Microbiota Transplant in a Mouse Model of Orthotopic Rectal Cancer. Front Oncol 2020;10:568012. [PMID: 33194651 DOI: 10.3389/fonc.2020.568012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
454 Chen H, Lu C, Lin C, Li L, Wang Y, Han R, Hu C, He Y. VPS34 suppression reverses osimertinib resistance via simultaneously inhibiting glycolysis and autophagy. Carcinogenesis 2021;42:880-90. [PMID: 33848354 DOI: 10.1093/carcin/bgab030] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
455 Nascimento Araujo CD, Amorim AT, Barbosa MS, Alexandre JCPL, Campos GB, Macedo CL, Marques LM, Timenetsky J. Evaluating the presence of Mycoplasma hyorhinis, Fusobacterium nucleatum, and Helicobacter pylori in biopsies of patients with gastric cancer. Infect Agent Cancer 2021;16:70. [PMID: 34949212 DOI: 10.1186/s13027-021-00410-2] [Reference Citation Analysis]
456 Whisner CM, Athena Aktipis C. The Role of the Microbiome in Cancer Initiation and Progression: How Microbes and Cancer Cells Utilize Excess Energy and Promote One Another's Growth. Curr Nutr Rep 2019;8:42-51. [PMID: 30758778 DOI: 10.1007/s13668-019-0257-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 8.0] [Reference Citation Analysis]
457 Cordero OJ, Varela-Calviño R. Oral hygiene might prevent cancer. Heliyon 2018;4:e00879. [PMID: 30417145 DOI: 10.1016/j.heliyon.2018.e00879] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
458 Wang G, Yu Y, Wang YZ, Wang JJ, Guan R, Sun Y, Shi F, Gao J, Fu XL. Role of SCFAs in gut microbiome and glycolysis for colorectal cancer therapy. J Cell Physiol 2019;234:17023-49. [PMID: 30888065 DOI: 10.1002/jcp.28436] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 11.7] [Reference Citation Analysis]
459 Zhang S, Cai S, Ma Y. Association between Fusobacterium nucleatum and colorectal cancer: Progress and future directions. J Cancer 2018;9:1652-9. [PMID: 29760804 DOI: 10.7150/jca.24048] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 8.0] [Reference Citation Analysis]
460 Ye X, Xie G, Liu Z, Tang J, Cui M, Wang C, Guo C, Tang J. TNNC1 Reduced Gemcitabine Sensitivity of Nonsmall-Cell Lung Cancer by Increasing Autophagy. Med Sci Monit 2020;26:e922703. [PMID: 32946432 DOI: 10.12659/MSM.922703] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
461 Anderson A, O'Sullivan J. The two faces of autophagy in oral squamous cell carcinoma. Arch Oral Biol 2021;134:105321. [PMID: 34923284 DOI: 10.1016/j.archoralbio.2021.105321] [Reference Citation Analysis]
462 Chen Y, Qin Y, Dai M, Liu L, Ni Y, Sun Q, Li L, Zhou Y, Qiu C, Jiang Y. IBSP, a potential recurrence biomarker, promotes the progression of colorectal cancer via Fyn/β-catenin signaling pathway. Cancer Med 2021;10:4030-45. [PMID: 33987980 DOI: 10.1002/cam4.3959] [Reference Citation Analysis]
463 Allegra A, Musolino C, Tonacci A, Pioggia G, Gangemi S. Interactions between the MicroRNAs and Microbiota in Cancer Development: Roles and Therapeutic Opportunities. Cancers (Basel) 2020;12:E805. [PMID: 32230762 DOI: 10.3390/cancers12040805] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 10.5] [Reference Citation Analysis]
464 Li B, Ge Y, Cheng L, Zeng B, Yu J, Peng X, Zhao J, Li W, Ren B, Li M, Wei H, Zhou X. Oral bacteria colonize and compete with gut microbiota in gnotobiotic mice. Int J Oral Sci 2019;11:10. [PMID: 30833566 DOI: 10.1038/s41368-018-0043-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
465 Panebianco C, Ciardiello D, Villani A, Maiorano BA, Latiano TP, Maiello E, Perri F, Pazienza V. Insights into the role of gut and intratumor microbiota in pancreatic ductal adenocarcinoma as new key players in preventive, diagnostic and therapeutic perspective. Semin Cancer Biol 2021:S1044-579X(21)00280-7. [PMID: 34838957 DOI: 10.1016/j.semcancer.2021.11.007] [Reference Citation Analysis]
466 Ai L, Ren Y, Li Y, Chen H, Qian Y, Lu S, Xu A, Ren L, Zhao S, Chen Z, Chen Y, Xu J, Fang J. Synbindin deficiency inhibits colon carcinogenesis by attenuating Wnt cascade and balancing gut microbiome. Int J Cancer 2019;145:206-20. [DOI: 10.1002/ijc.32074] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
467 Yixia Y, Sripetchwandee J, Chattipakorn N, Chattipakorn SC. The alterations of microbiota and pathological conditions in the gut of patients with colorectal cancer undergoing chemotherapy. Anaerobe 2021;68:102361. [PMID: 33781900 DOI: 10.1016/j.anaerobe.2021.102361] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
468 Wang L, Cho KB, Li Y, Tao G, Xie Z, Guo B. Long Noncoding RNA (lncRNA)-Mediated Competing Endogenous RNA Networks Provide Novel Potential Biomarkers and Therapeutic Targets for Colorectal Cancer. Int J Mol Sci 2019;20:E5758. [PMID: 31744051 DOI: 10.3390/ijms20225758] [Cited by in Crossref: 89] [Cited by in F6Publishing: 114] [Article Influence: 29.7] [Reference Citation Analysis]
469 Shi Y, Zheng W, Yang K, Harris KG, Ni K, Xue L, Lin W, Chang EB, Weichselbaum RR, Fu YX. Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signaling. J Exp Med 2020;217:e20192282. [PMID: 32142585 DOI: 10.1084/jem.20192282] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 16.0] [Reference Citation Analysis]
470 Koi M, Tseng-Rogenski SS, Carethers JM. Inflammation-associated microsatellite alterations: Mechanisms and significance in the prognosis of patients with colorectal cancer. World J Gastrointest Oncol 2018; 10(1): 1-14 [PMID: 29375743 DOI: 10.4251/wjgo.v10.i1.1] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 28] [Article Influence: 6.3] [Reference Citation Analysis]
471 Li C, Yao H, Wang H, Fang JY, Xu J. Repurposing screen identifies Amlodipine as an inducer of PD-L1 degradation and antitumor immunity. Oncogene 2021;40:1128-46. [PMID: 33323966 DOI: 10.1038/s41388-020-01592-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
472 Tourelle KM, Boutin S, Weigand MA, Schmitt FCF. The Association of Gut Microbiota and Complications in Gastrointestinal-Cancer Therapies. Biomedicines 2021;9:1305. [PMID: 34680424 DOI: 10.3390/biomedicines9101305] [Reference Citation Analysis]
473 Matson V, Chervin CS, Gajewski TF. Cancer and the Microbiome-Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy. Gastroenterology 2021;160:600-13. [PMID: 33253684 DOI: 10.1053/j.gastro.2020.11.041] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
474 Elkrief A, Derosa L, Kroemer G, Zitvogel L, Routy B. The negative impact of antibiotics on outcomes in cancer patients treated with immunotherapy: a new independent prognostic factor? Ann Oncol 2019;30:1572-9. [PMID: 31268133 DOI: 10.1093/annonc/mdz206] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 28.0] [Reference Citation Analysis]
475 Mola S, Pandolfo C, Sica A, Porta C. The Macrophages-Microbiota Interplay in Colorectal Cancer (CRC)-Related Inflammation: Prognostic and Therapeutic Significance. Int J Mol Sci 2020;21:E6866. [PMID: 32962159 DOI: 10.3390/ijms21186866] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
476 Cheng WY, Wu CY, Yu J. The role of gut microbiota in cancer treatment: friend or foe? Gut 2020;69:1867-76. [PMID: 32759302 DOI: 10.1136/gutjnl-2020-321153] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 12.5] [Reference Citation Analysis]
477 Tomkovich S, Gharaibeh RZ, Dejea CM, Pope JL, Jiang J, Winglee K, Gauthier J, Newsome RC, Yang Y, Fodor AA, Schmittgen TD, Sears CL, Jobin C. Human Colon Mucosal Biofilms and Murine Host Communicate via Altered mRNA and microRNA Expression during Cancer. mSystems 2020;5:e00451-19. [PMID: 31937674 DOI: 10.1128/mSystems.00451-19] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
478 Amatya SB, Salmi S, Kainulainen V, Karihtala P, Reunanen J. Bacterial Extracellular Vesicles in Gastrointestinal Tract Cancer: An Unexplored Territory. Cancers (Basel) 2021;13:5450. [PMID: 34771614 DOI: 10.3390/cancers13215450] [Reference Citation Analysis]
479 Xu T, Xie M, Jing X, Cui J, Wu X, Shu Y. Crosstalk between Environmental Inflammatory Stimuli and Non-Coding RNA in Cancer Occurrence and Development. Cancers (Basel) 2021;13:4436. [PMID: 34503246 DOI: 10.3390/cancers13174436] [Reference Citation Analysis]
480 Chen D, Wu J, Jin D, Wang B, Cao H. Fecal microbiota transplantation in cancer management: Current status and perspectives. Int J Cancer. 2018;. [PMID: 30458058 DOI: 10.1002/ijc.32003] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 15.0] [Reference Citation Analysis]
481 Koulouridi A, Messaritakis I, Theodorakis E, Chondrozoumaki M, Sfakianaki M, Gouvas N, Tsiaoussis J, Mavroudis D, Tzardi M, Souglakos J. Detection of Circulating Tumor Cells and Microbial DNA Fragments in Stage III Colorectal Cancer Patients under Three versus Six Months of Adjuvant Treatment. Cancers (Basel) 2021;13:3552. [PMID: 34298766 DOI: 10.3390/cancers13143552] [Reference Citation Analysis]
482 Liu W, Zhang R, Shu R, Yu J, Li H, Long H, Jin S, Li S, Hu Q, Yao F, Zhou C, Huang Q, Hu X, Chen M, Hu W, Wang Q, Fang S, Wu Q. Study of the Relationship between Microbiome and Colorectal Cancer Susceptibility Using 16SrRNA Sequencing. Biomed Res Int. 2020;2020:7828392. [PMID: 32083132 DOI: 10.1155/2020/7828392] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
483 Zhou B, Yuan Y, Zhang S, Guo C, Li X, Li G, Xiong W, Zeng Z. Intestinal Flora and Disease Mutually Shape the Regional Immune System in the Intestinal Tract. Front Immunol 2020;11:575. [PMID: 32318067 DOI: 10.3389/fimmu.2020.00575] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
484 Dutta D, Lim SH. Bidirectional interaction between intestinal microbiome and cancer: opportunities for therapeutic interventions. Biomark Res. 2020;8:31. [PMID: 32817793 DOI: 10.1186/s40364-020-00211-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
485 Wu M, Hou P, Dong L, Cai L, Chen Z, Zhao M, Li J. Manganese dioxide nanosheets: from preparation to biomedical applications. Int J Nanomedicine 2019;14:4781-800. [PMID: 31308658 DOI: 10.2147/IJN.S207666] [Cited by in Crossref: 26] [Cited by in F6Publishing: 7] [Article Influence: 8.7] [Reference Citation Analysis]
486 Inamura K. Roles of microbiota in response to cancer immunotherapy. Semin Cancer Biol 2020;65:164-75. [PMID: 31911189 DOI: 10.1016/j.semcancer.2019.12.026] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
487 Kosnicki KL, Penprase JC, Cintora P, Torres PJ, Harris GL, Brasser SM, Kelley ST. Effects of moderate, voluntary ethanol consumption on the rat and human gut microbiome. Addict Biol 2019;24:617-30. [PMID: 29750384 DOI: 10.1111/adb.12626] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
488 Zhu Z, Huang J, Li X, Xing J, Chen Q, Liu R, Hua F, Qiu Z, Song Y, Bai C, Mo YY, Zhang Z. Gut microbiota regulate tumor metastasis via circRNA/miRNA networks. Gut Microbes. 2020;12:1788891. [PMID: 32686598 DOI: 10.1080/19490976.2020.1788891] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
489 Yan Z, Bi M, Zhang Q, Song Y, Hong S. LncRNA TUG1 promotes the progression of colorectal cancer via the miR-138-5p/ZEB2 axis. Biosci Rep 2020;40:BSR20201025. [PMID: 32391554 DOI: 10.1042/BSR20201025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
490 Sun Q, Hou X, Yang J, Zhang M, Yang Y, Liu Y, Shen W, Yin D. Heparin-Coated Photosensitive Metal-Organic Frameworks as Drug Delivery Nanoplatforms of Autophagy Inhibitors for Sensitized Photodynamic Therapy against Breast Cancer. ACS Appl Mater Interfaces 2021;13:55577-90. [PMID: 34762394 DOI: 10.1021/acsami.1c18055] [Reference Citation Analysis]
491 Sharma A, Gilbert JA. Microbial exposure and human health. Current Opinion in Microbiology 2018;44:79-87. [DOI: 10.1016/j.mib.2018.08.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
492 Guo S, Lu Y, Xu B, Wang W, Xu J, Zhang G. A Simple Fecal Bacterial Marker Panel for the Diagnosis of Crohn's Disease. Front Microbiol. 2019;10:1306. [PMID: 31244813 DOI: 10.3389/fmicb.2019.01306] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
493 Niederreiter L, Adolph TE, Tilg H. Food, microbiome and colorectal cancer. Dig Liver Dis 2018;50:647-52. [PMID: 29705028 DOI: 10.1016/j.dld.2018.03.030] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
494 Casasanta MA, Yoo CC, Udayasuryan B, Sanders BE, Umaña A, Zhang Y, Peng H, Duncan AJ, Wang Y, Li L, Verbridge SS, Slade DJ. Fusobacterium nucleatum host-cell binding and invasion induces IL-8 and CXCL1 secretion that drives colorectal cancer cell migration. Sci Signal 2020;13:eaba9157. [PMID: 32694172 DOI: 10.1126/scisignal.aba9157] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 13.0] [Reference Citation Analysis]
495 Shahnazari M, Samadi P, Pourjafar M, Jalali A. Cell-based immunotherapy approaches for colorectal cancer: main achievements and challenges. Future Oncol 2021;17:3253-70. [PMID: 34156258 DOI: 10.2217/fon-2020-1218] [Reference Citation Analysis]
496 Jiang CF, Xie YX, Qian YC, Wang M, Liu LZ, Shu YQ, Bai XM, Jiang BH. TBX15/miR-152/KIF2C pathway regulates breast cancer doxorubicin resistance via promoting PKM2 ubiquitination. Cancer Cell Int 2021;21:542. [PMID: 34663310 DOI: 10.1186/s12935-021-02235-w] [Reference Citation Analysis]
497 Ma R, Li X, Liu H, Jiang R, Yang M, Zhang M, Wang Y, Zhao Y, Li H. GATA6-upregulating autophagy promotes TKI resistance in nonsmall cell lung cancer. Cancer Biol Ther 2019;20:1206-12. [PMID: 31092103 DOI: 10.1080/15384047.2019.1599665] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
498 Aguilar C, Mano M, Eulalio A. MicroRNAs at the Host-Bacteria Interface: Host Defense or Bacterial Offense. Trends Microbiol 2019;27:206-18. [PMID: 30477908 DOI: 10.1016/j.tim.2018.10.011] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 9.8] [Reference Citation Analysis]
499 Qiao Z, Han J, Feng H, Zheng H, Wu J, Gao C, Yang M, You C, Liu Z, Wu Z. Fermentation Products of Paenibacillus bovis sp. nov. BD3526 Alleviates the Symptoms of Type 2 Diabetes Mellitus in GK Rats. Front Microbiol 2018;9:3292. [PMID: 30687277 DOI: 10.3389/fmicb.2018.03292] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
500 Yan X, Chen Q, An J, Liu D, Huang Y, Yang R, Li W, Chen L, Gao H. Hyaluronic acid/PEGylated amphiphilic nanoparticles for pursuit of selective intracellular doxorubicin release. J Mater Chem B 2019;7:95-102. [DOI: 10.1039/c8tb02370k] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
501 Wang Z, Xiao R, Huang J, Qin X, Hu D, Guo E, Liu C, Lu F, You L, Sun C, Chen G. The Diversity of Vaginal Microbiota Predicts Neoadjuvant Chemotherapy Responsiveness in Locally Advanced Cervical Cancer. Microb Ecol 2021. [PMID: 34405250 DOI: 10.1007/s00248-021-01800-0] [Reference Citation Analysis]
502 Seong J, Lee J, Lim YK, Yoon WJ, Jung S, Kook JK, Lee TH. Osmunda japonica Extract Suppresses Pro-Inflammatory Cytokines by Downregulating NF-κB Activation in Periodontal Ligament Fibroblasts Infected with Oral Pathogenic Bacteria. Int J Mol Sci 2020;21:E2453. [PMID: 32244806 DOI: 10.3390/ijms21072453] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
503 Khalyfa AA, Punatar S, Aslam R, Yarbrough A. Exploring the Inflammatory Pathogenesis of Colorectal Cancer. Diseases 2021;9:79. [PMID: 34842660 DOI: 10.3390/diseases9040079] [Reference Citation Analysis]
504 Zhou J, Liu J, Gao Y, Shen L, Li S, Chen S. miRNA-Based Potential Biomarkers and New Molecular Insights in Ulcerative Colitis. Front Pharmacol 2021;12:707776. [PMID: 34305614 DOI: 10.3389/fphar.2021.707776] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
505 Avilés-jiménez F, Yu G, Torres-poveda K, Madrid-marina V, Torres J. On the Search to Elucidate the Role of Microbiota in the Genesis of Cancer: The Cases of Gastrointestinal and Cervical Cancer. Archives of Medical Research 2017;48:754-65. [DOI: 10.1016/j.arcmed.2017.11.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
506 Reynolds IS, Thomas V, O'Connell E, Fichtner M, McNamara DA, Kay EW, Prehn JHM, Burke JP, Furney SJ. Mucinous Adenocarcinoma of the Rectum: A Whole Genome Sequencing Study. Front Oncol 2020;10:1682. [PMID: 32984045 DOI: 10.3389/fonc.2020.01682] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
507 Lu Z, Ren Y, Yang L, Jia A, Hu Y, Zhao Y, Zhao W, Yu B, Zhao W, Zhang J, Hou G. Inhibiting autophagy enhances sulforaphane-induced apoptosis via targeting NRF2 in esophageal squamous cell carcinoma. Acta Pharm Sin B 2021;11:1246-60. [PMID: 34094831 DOI: 10.1016/j.apsb.2020.12.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
508 Okuda S, Shimada Y, Tajima Y, Yuza K, Hirose Y, Ichikawa H, Nagahashi M, Sakata J, Ling Y, Miura N, Sugai M, Watanabe Y, Takeuchi S, Wakai T. Profiling of host genetic alterations and intra-tumor microbiomes in colorectal cancer. Comput Struct Biotechnol J 2021;19:3330-8. [PMID: 34188781 DOI: 10.1016/j.csbj.2021.05.049] [Reference Citation Analysis]
509 Lin LT, Shi YC, Choong CY, Tai CJ. The Fruits of Paris polyphylla Inhibit Colorectal Cancer Cell Migration Induced by Fusobacterium nucleatum-Derived Extracellular Vesicles. Molecules 2021;26:4081. [PMID: 34279421 DOI: 10.3390/molecules26134081] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
510 Dieterich LC, Bikfalvi A. The tumor organismal environment: Role in tumor development and cancer immunotherapy. Seminars in Cancer Biology 2020;65:197-206. [DOI: 10.1016/j.semcancer.2019.12.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
511 Flemer B, Herlihy M, O'Riordain M, Shanahan F, O'Toole PW. Tumour-associated and non-tumour-associated microbiota: Addendum. Gut Microbes 2018;9:369-73. [PMID: 29420132 DOI: 10.1080/19490976.2018.1435246] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
512 Dohlman AB, Arguijo Mendoza D, Ding S, Gao M, Dressman H, Iliev ID, Lipkin SM, Shen X. The cancer microbiome atlas: a pan-cancer comparative analysis to distinguish tissue-resident microbiota from contaminants. Cell Host Microbe 2021;29:281-298.e5. [PMID: 33382980 DOI: 10.1016/j.chom.2020.12.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
513 Zhu L, Zhu Y, Han S, Chen M, Song P, Dai D, Xu W, Jiang T, Feng L, Shin VY, Wang X, Jin H. Impaired autophagic degradation of lncRNA ARHGAP5-AS1 promotes chemoresistance in gastric cancer. Cell Death Dis 2019;10:383. [PMID: 31097692 DOI: 10.1038/s41419-019-1585-2] [Cited by in Crossref: 37] [Cited by in F6Publishing: 46] [Article Influence: 12.3] [Reference Citation Analysis]
514 Gur C, Maalouf N, Shhadeh A, Berhani O, Singer BB, Bachrach G, Mandelboim O. Fusobacterium nucleatum supresses anti-tumor immunity by activating CEACAM1. Oncoimmunology 2019;8:e1581531. [PMID: 31069151 DOI: 10.1080/2162402X.2019.1581531] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
515 Peng C, Li N, Hu Y, Lu N. Impact factors that modulate gastric cancer risk in Helicobacter pylori ‐infected rodent models. Helicobacter 2019. [DOI: 10.1111/hel.12580] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
516 Chen X, Li P, Liu M, Zheng H, He Y, Chen MX, Tang W, Yue X, Huang Y, Zhuang L, Wang Z, Zhong M, Ke G, Hu H, Feng Y, Chen Y, Yu Y, Zhou H, Huang L. Gut dysbiosis induces the development of pre-eclampsia through bacterial translocation. Gut 2020;69:513-22. [PMID: 31900289 DOI: 10.1136/gutjnl-2019-319101] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 14.5] [Reference Citation Analysis]
517 Jiang Z, Sun TY, He Y, Gou W, Zuo LS, Fu Y, Miao Z, Shuai M, Xu F, Xiao C, Liang Y, Wang J, Xu Y, Jing LP, Ling W, Zhou H, Chen YM, Zheng JS. Dietary fruit and vegetable intake, gut microbiota, and type 2 diabetes: results from two large human cohort studies. BMC Med 2020;18:371. [PMID: 33267887 DOI: 10.1186/s12916-020-01842-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
518 Guo S, Chen J, Chen F, Zeng Q, Liu WL, Zhang G. Exosomes derived from Fusobacterium nucleatum-infected colorectal cancer cells facilitate tumour metastasis by selectively carrying miR-1246/92b-3p/27a-3p and CXCL16. Gut 2020:gutjnl-2020-321187. [PMID: 33172926 DOI: 10.1136/gutjnl-2020-321187] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
519 Choi S, Chung J, Cho ML, Park D, Choi SS. Analysis of changes in microbiome compositions related to the prognosis of colorectal cancer patients based on tissue-derived 16S rRNA sequences. J Transl Med 2021;19:485. [PMID: 34844611 DOI: 10.1186/s12967-021-03154-0] [Reference Citation Analysis]
520 Xu H, Hou Q, Zhu J, Feng M, Wang P, Pan Y. The protective effect of Escherichia coli Nissle 1917 on the intestinal barrier is mediated by inhibition of RhoA/ROCK2/MLC signaling via TLR-4. Life Sci 2022;:120330. [PMID: 35051420 DOI: 10.1016/j.lfs.2022.120330] [Reference Citation Analysis]
521 Wang Z, Hopson LM, Singleton SS, Yang X, Jogunoori W, Mazumder R, Obias V, Lin P, Nguyen BN, Yao M, Miller L, White J, Rao S, Mishra L. Mice with dysfunctional TGF-β signaling develop altered intestinal microbiome and colorectal cancer resistant to 5FU. Biochim Biophys Acta Mol Basis Dis 2021;1867:166179. [PMID: 34082069 DOI: 10.1016/j.bbadis.2021.166179] [Reference Citation Analysis]
522 Ponath F, Tawk C, Zhu Y, Barquist L, Faber F, Vogel J. RNA landscape of the emerging cancer-associated microbe Fusobacterium nucleatum. Nat Microbiol 2021;6:1007-20. [PMID: 34239075 DOI: 10.1038/s41564-021-00927-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
523 El Bairi K, Jabi R, Trapani D, Boutallaka H, Ouled Amar Bencheikh B, Bouziane M, Amrani M, Afqir S, Maleb A. Can the microbiota predict response to systemic cancer therapy, surgical outcomes, and survival? The answer is in the gut. Expert Rev Clin Pharmacol 2020;13:403-21. [PMID: 32308061 DOI: 10.1080/17512433.2020.1758063] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
524 Zhang X, Zhu X, Cao Y, Fang JY, Hong J, Chen H. Fecal Fusobacterium nucleatum for the diagnosis of colorectal tumor: A systematic review and meta-analysis. Cancer Med 2019;8:480-91. [PMID: 30636375 DOI: 10.1002/cam4.1850] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
525 Jin L, Chen Y, Cheng D, He Z, Shi X, Du B, Xi X, Gao Y, Guo Y. YAP inhibits autophagy and promotes progression of colorectal cancer via upregulating Bcl-2 expression. Cell Death Dis 2021;12:457. [PMID: 33963173 DOI: 10.1038/s41419-021-03722-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
526 Zhao Y, Wang C, Goel A. Role of gut microbiota in epigenetic regulation of colorectal Cancer. Biochim Biophys Acta Rev Cancer 2021;1875:188490. [PMID: 33321173 DOI: 10.1016/j.bbcan.2020.188490] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
527 Cong J, Zhu J, Zhang C, Li T, Liu K, Liu D, Zhou N, Jiang M, Hou H, Zhang X. Chemotherapy Alters the Phylogenetic Molecular Ecological Networks of Intestinal Microbial Communities. Front Microbiol 2019;10:1008. [PMID: 31134034 DOI: 10.3389/fmicb.2019.01008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
528 Vacante M, Ciuni R, Basile F, Biondi A. Gut Microbiota and Colorectal Cancer Development: A Closer Look to the Adenoma-Carcinoma Sequence. Biomedicines. 2020;8. [PMID: 33182693 DOI: 10.3390/biomedicines8110489] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
529 Huang ST, Chen J, Lian LY, Cai HH, Zeng HS, Zheng M, Liu MB. Intratumoral levels and prognostic significance of Fusobacterium nucleatum in cervical carcinoma. Aging (Albany NY) 2020;12:23337-50. [PMID: 33197886 DOI: 10.18632/aging.104188] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
530 Rubinstein MR, Baik JE, Lagana SM, Han RP, Raab WJ, Sahoo D, Dalerba P, Wang TC, Han YW. Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt/β-catenin modulator Annexin A1. EMBO Rep 2019;20:e47638. [PMID: 30833345 DOI: 10.15252/embr.201847638] [Cited by in Crossref: 77] [Cited by in F6Publishing: 79] [Article Influence: 25.7] [Reference Citation Analysis]
531 Jiang Y, Guo Z, Fang J, Wang B, Lin Z, Chen ZS, Chen Y, Zhang N, Yang X, Gao W. A multi-functionalized nanocomposite constructed by gold nanorod core with triple-layer coating to combat multidrug resistant colorectal cancer. Mater Sci Eng C Mater Biol Appl 2020;107:110224. [PMID: 31761194 DOI: 10.1016/j.msec.2019.110224] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
532 Englinger B, Pirker C, Heffeter P, Terenzi A, Kowol CR, Keppler BK, Berger W. Metal Drugs and the Anticancer Immune Response. Chem Rev 2019;119:1519-624. [DOI: 10.1021/acs.chemrev.8b00396] [Cited by in Crossref: 108] [Cited by in F6Publishing: 91] [Article Influence: 27.0] [Reference Citation Analysis]
533 Li W, Tanikawa T, Kryczek I, Xia H, Li G, Wu K, Wei S, Zhao L, Vatan L, Wen B, Shu P, Sun D, Kleer C, Wicha M, Sabel M, Tao K, Wang G, Zou W. Aerobic Glycolysis Controls Myeloid-Derived Suppressor Cells and Tumor Immunity via a Specific CEBPB Isoform in Triple-Negative Breast Cancer. Cell Metab 2018;28:87-103.e6. [PMID: 29805099 DOI: 10.1016/j.cmet.2018.04.022] [Cited by in Crossref: 100] [Cited by in F6Publishing: 97] [Article Influence: 25.0] [Reference Citation Analysis]
534 Yang Y, Jobin C. Colorectal cancer: Hand-in-hand - colorectal cancer metastasizes with microorganisms. Nat Rev Gastroenterol Hepatol 2018;15:133-4. [PMID: 29339812 DOI: 10.1038/nrgastro.2017.186] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
535 Li Q, Wang H, Tan L, Zhang S, Lin L, Tang X, Pan Y. Oral Pathogen Fusobacterium nucleatum Coaggregates With Pseudomonas aeruginosa to Modulate the Inflammatory Cytotoxicity of Pulmonary Epithelial Cells. Front Cell Infect Microbiol 2021;11:643913. [PMID: 33816348 DOI: 10.3389/fcimb.2021.643913] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
536 Liu H, Yang J, Yan X, Li C, Elsabahy M, Chen L, Yang YW, Gao H. A dendritic polyamidoamine supramolecular system composed of pillar[5]arene and azobenzene for targeting drug-resistant colon cancer. J Mater Chem B 2021;9:9594-605. [PMID: 34783814 DOI: 10.1039/d1tb02134f] [Reference Citation Analysis]
537 Wei X, Tang Z, Wu H, Zuo X, Dong H, Tan L, Wang W, Liu Y, Wu Z, Shi L, Wang N, Li X, Xiao X, Guo Z. Biofunctional magnesium-coated Ti6Al4V scaffolds promote autophagy-dependent apoptosis in osteosarcoma by activating the AMPK/mTOR/ULK1 signaling pathway. Mater Today Bio 2021;12:100147. [PMID: 34704011 DOI: 10.1016/j.mtbio.2021.100147] [Reference Citation Analysis]
538 Norvaisas P, Cabreiro F. Pharmacology in the age of the holobiont. Current Opinion in Systems Biology 2018;10:34-42. [DOI: 10.1016/j.coisb.2018.05.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
539 Kasper SH, Morell-Perez C, Wyche TP, Sana TR, Lieberman LA, Hett EC. Colorectal cancer-associated anaerobic bacteria proliferate in tumor spheroids and alter the microenvironment. Sci Rep 2020;10:5321. [PMID: 32210258 DOI: 10.1038/s41598-020-62139-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
540 Park R, Umar S, Kasi A. Immunotherapy in Colorectal Cancer: Potential of Fecal Transplant and Microbiota-augmented Clinical Trials. Curr Colorectal Cancer Rep 2020;16:81-8. [PMID: 32607098 DOI: 10.1007/s11888-020-00456-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
541 Liu T, Song X, Khan S, Li Y, Guo Z, Li C, Wang S, Dong W, Liu W, Wang B, Cao H. The gut microbiota at the intersection of bile acids and intestinal carcinogenesis: An old story, yet mesmerizing. Int J Cancer 2019;146:1780-90. [DOI: 10.1002/ijc.32563] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
542 Hou J, Karin M, Sun B. Targeting cancer-promoting inflammation - have anti-inflammatory therapies come of age? Nat Rev Clin Oncol 2021;18:261-79. [PMID: 33469195 DOI: 10.1038/s41571-020-00459-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
543 Han M, Qian X, Cao H, Wang F, Li X, Han N, Yang X, Yang Y, Dou D, Hu J, Wang W, Han J, Zhang F, Dong H. lncRNA ZNF649-AS1 Induces Trastuzumab Resistance by Promoting ATG5 Expression and Autophagy. Mol Ther 2020;28:2488-502. [PMID: 32735773 DOI: 10.1016/j.ymthe.2020.07.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
544 Wei MY, Shi S, Liang C, Meng QC, Hua J, Zhang YY, Liu J, Zhang B, Xu J, Yu XJ. The microbiota and microbiome in pancreatic cancer: more influential than expected. Mol Cancer 2019;18:97. [PMID: 31109338 DOI: 10.1186/s12943-019-1008-0] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 17.7] [Reference Citation Analysis]
545 Oliva M, Schneeberger PHH, Rey V, Cho M, Taylor R, Hansen AR, Taylor K, Hosni A, Bayley A, Hope AJ, Bratman SV, Ringash J, Singh S, Weinreb I, Perez-Ordoñez B, Chepeha D, Waldron J, Xu W, Guttman D, Siu LL, Coburn B, Spreafico A. Transitions in oral and gut microbiome of HPV+ oropharyngeal squamous cell carcinoma following definitive chemoradiotherapy (ROMA LA-OPSCC study). Br J Cancer 2021;124:1543-51. [PMID: 33750907 DOI: 10.1038/s41416-020-01253-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
546 Avgerinos KI, Spyrou N, Mantzoros CS, Dalamaga M. Obesity and cancer risk: Emerging biological mechanisms and perspectives. Metabolism. 2019;92:121-135. [PMID: 30445141 DOI: 10.1016/j.metabol.2018.11.001] [Cited by in Crossref: 188] [Cited by in F6Publishing: 176] [Article Influence: 47.0] [Reference Citation Analysis]
547 Song X, Greiner-Tollersrud OK, Zhou H. Oral Microbiota Variation: A Risk Factor for Development and Poor Prognosis of Esophageal Cancer. Dig Dis Sci 2021. [PMID: 34505256 DOI: 10.1007/s10620-021-07245-2] [Reference Citation Analysis]
548 Mangifesta M, Mancabelli L, Milani C, Gaiani F, de'Angelis N, de'Angelis GL, van Sinderen D, Ventura M, Turroni F. Mucosal microbiota of intestinal polyps reveals putative biomarkers of colorectal cancer. Sci Rep 2018;8:13974. [PMID: 30228361 DOI: 10.1038/s41598-018-32413-2] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 12.3] [Reference Citation Analysis]
549 Lu P, Xu M, Xiong Z, Zhou F, Wang L. Fusobacterium nucleatum prevents apoptosis in colorectal cancer cells via the ANO1 pathway. Cancer Manag Res 2019;11:9057-66. [PMID: 31802939 DOI: 10.2147/CMAR.S185766] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
550 Tilg H, Adolph TE, Gerner RR, Moschen AR. The Intestinal Microbiota in Colorectal Cancer. Cancer Cell. 2018;33:954-964. [PMID: 29657127 DOI: 10.1016/j.ccell.2018.03.004] [Cited by in Crossref: 235] [Cited by in F6Publishing: 221] [Article Influence: 58.8] [Reference Citation Analysis]
551 Rinninella E, Raoul P, Cintoni M, Palombaro M, Pulcini G, Gasbarrini A, Mele MC. Nutritional Interventions Targeting Gut Microbiota during Cancer Therapies. Microorganisms 2021;9:1469. [PMID: 34361904 DOI: 10.3390/microorganisms9071469] [Reference Citation Analysis]
552 Huang QY, Yao F, Zhou CR, Huang XY, Wang Q, Long H, Wu QM. Role of gut microbiome in regulating the effectiveness of metformin in reducing colorectal cancer in type 2 diabetes. World J Clin Cases 2020; 8(24): 6213-6228 [PMID: 33392303 DOI: 10.12998/wjcc.v8.i24.6213] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
553 He X, Xiong LH, Zhao Z, Wang Z, Luo L, Lam JWY, Kwok RTK, Tang BZ. AIE-based theranostic systems for detection and killing of pathogens. Theranostics 2019;9:3223-48. [PMID: 31244951 DOI: 10.7150/thno.31844] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 18.7] [Reference Citation Analysis]
554 Feng J, Zhang Y, Ren X, Li D, Fu H, Liu C, Zhou W, Liu Q, Liu Q, Wu M. Leucine-rich repeat containing 4 act as an autophagy inhibitor that restores sensitivity of glioblastoma to temozolomide. Oncogene 2020;39:4551-66. [PMID: 32372061 DOI: 10.1038/s41388-020-1312-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
555 Jiang J, Chen S, Li K, Zhang C, Tan Y, Deng Q, Chai Y, Wang X, Chen G, Feng K, Zhang L, Xie C, Ma K. Targeting autophagy enhances heat stress-induced apoptosis via the ATP-AMPK-mTOR axis for hepatocellular carcinoma. International Journal of Hyperthermia 2019;36:498-509. [DOI: 10.1080/02656736.2019.1600052] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
556 Cani PD, Jordan BF. Gut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer. Nat Rev Gastroenterol Hepatol. 2018;15:671-682. [PMID: 29844585 DOI: 10.1038/s41575-018-0025-6] [Cited by in Crossref: 104] [Cited by in F6Publishing: 102] [Article Influence: 34.7] [Reference Citation Analysis]
557 Deng ZL, Sztajer H, Jarek M, Bhuju S, Wagner-Döbler I. Worlds Apart - Transcriptome Profiles of Key Oral Microbes in the Periodontal Pocket Compared to Single Laboratory Culture Reflect Synergistic Interactions. Front Microbiol 2018;9:124. [PMID: 29467738 DOI: 10.3389/fmicb.2018.00124] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 5.8] [Reference Citation Analysis]
558 Deng Y, Song P, Chen X, Huang Y, Hong L, Jin Q, Ji J. 3-Bromopyruvate-Conjugated Nanoplatform-Induced Pro-Death Autophagy for Enhanced Photodynamic Therapy against Hypoxic Tumor. ACS Nano 2020;14:9711-27. [DOI: 10.1021/acsnano.0c01350] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
559 Oh HJ, Kim JH, Bae JM, Kim HJ, Cho NY, Kang GH. Prognostic Impact of Fusobacterium nucleatum Depends on Combined Tumor Location and Microsatellite Instability Status in Stage II/III Colorectal Cancers Treated with Adjuvant Chemotherapy. J Pathol Transl Med 2019;53:40-9. [PMID: 30586952 DOI: 10.4132/jptm.2018.11.29] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
560 Reitano E, de'Angelis N, Gavriilidis P, Gaiani F, Memeo R, Inchingolo R, Bianchi G, de'Angelis GL, Carra MC. Oral Bacterial Microbiota in Digestive Cancer Patients: A Systematic Review. Microorganisms 2021;9:2585. [PMID: 34946186 DOI: 10.3390/microorganisms9122585] [Reference Citation Analysis]
561 Gu S, Zaidi S, Hassan MI, Mohammad T, Malta TM, Noushmehr H, Nguyen B, Crandall KA, Srivastav J, Obias V, Lin P, Nguyen BN, Yao M, Yao R, King CH, Mazumder R, Mishra B, Rao S, Mishra L. Mutated CEACAMs Disrupt Transforming Growth Factor Beta Signaling and Alter the Intestinal Microbiome to Promote Colorectal Carcinogenesis. Gastroenterology 2020;158:238-52. [PMID: 31585122 DOI: 10.1053/j.gastro.2019.09.023] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
562 Sun J, Jia H, Bao X, Wu Y, Zhu T, Li R, Zhao H. Tumor exosome promotes Th17 cell differentiation by transmitting the lncRNA CRNDE-h in colorectal cancer. Cell Death Dis. 2021;12:123. [PMID: 33495437 DOI: 10.1038/s41419-020-03376-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
563 Zhang S, Wang Q, Zhou C, Chen K, Chang H, Xiao W, Gao Y. Colorectal cancer, radiotherapy and gut microbiota. Chin J Cancer Res 2019;31:212-22. [PMID: 30996579 DOI: 10.21147/j.issn.1000-9604.2019.01.16] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
564 Blaustein RA, Seed PC, Hartmann EM. Biotransformation of Doxorubicin Promotes Resilience in Simplified Intestinal Microbial Communities. mSphere 2021;6:e0006821. [PMID: 34192503 DOI: 10.1128/mSphere.00068-21] [Reference Citation Analysis]
565 Gong X, Li J, Tan T, Wang Z, Wang H, Wang Y, Xu X, Zhang Z, Li Y. Emerging Approaches of Cell‐Based Nanosystems to Target Cancer Metastasis. Adv Funct Mater 2019;29:1903441. [DOI: 10.1002/adfm.201903441] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 5.7] [Reference Citation Analysis]
566 Liu X, Cheng Y, Shao L, Ling Z. Alterations of the Predominant Fecal Microbiota and Disruption of the Gut Mucosal Barrier in Patients with Early-Stage Colorectal Cancer. Biomed Res Int. 2020;2020:2948282. [PMID: 32280686 DOI: 10.1155/2020/2948282] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
567 Liu CJ, Chen SQ, Zhang SY, Wang JL, Tang XD, Yang KX, Li XR. The comparison of microbial communities in thyroid tissues from thyroid carcinoma patients. J Microbiol 2021;59:988-1001. [PMID: 34613604 DOI: 10.1007/s12275-021-1271-9] [Reference Citation Analysis]